<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Atorvastatin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Atorvastatin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Atorvastatin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Atorvastatin</b>, sold under the brand name <b>Lipitor</b> among others, is a statin medication used to prevent cardiovascular disease in those at high risk and treat abnormal lipid levels.<span class="mw-ref" id="cite_ref-AHFS2018_2-0"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> For the prevention of cardiovascular disease, statins are a first-line treatment.<span class="mw-ref" id="cite_ref-AHFS2018_2-1"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2018_2-2"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>



<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Atorvastatin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Atorvastatin.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Atorvastatin.svg.png" data-file-width="512" data-file-height="264" data-file-type="drawing" height="142" width="275"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Atorvastatin-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Atorvastatin-3D-balls.png" data-file-width="1100" data-file-height="735" data-file-type="bitmap" height="167" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>ə</span><span>ˌ</span><span>t</span><span>ɔːr</span><span>v</span><span>ə</span><span>ˈ</span><span>s</span><span>t</span><span>æ</span><span>t</span><span>ən</span></span>/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Lipitor, Sortis, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/lipitor.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/lipitor.html'" tppabs="https://www.drugs.com/monograph/lipitor.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a600045.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a600045.html'" tppabs="https://medlineplus.gov/druginfo/meds/a600045.html" class="external text external">a600045</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Atorvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Atorvastatin'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Atorvastatin" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Atorvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Atorvastatin'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Atorvastatin" class="external text external">Atorvastatin</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Atorvastatin&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Atorvastatin&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Atorvastatin&SearchType=BasicSearch" class="external text external">Atorvastatin</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>D<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>N (Not classified yet)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul><li>Contraindicated<span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-2"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>C10AA05<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10AA05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10AA05'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10AA05" class="external text external">WHO</a></span>)<span> </span>C10BX08<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX08'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX08" class="external text external">WHO</a></span>) C10BX03<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX03  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX03'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX03" class="external text external">WHO</a></span>) C10BA05<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BA05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BA05'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BA05" class="external text external">WHO</a></span>) C10BA08<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BA08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BA08'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BA08" class="external text external">WHO</a></span>) C10BX15<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX15  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX15'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX15" class="external text external">WHO</a></span>) C10BX12<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX12'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX12" class="external text external">WHO</a></span>) C10BX06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX06'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX06" class="external text external">WHO</a></span>) C10BX11<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10BX11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10BX11'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10BX11" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>12%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (CYP3A4)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>14 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Bile</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(3<i>R</i>,5<i>R</i>)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=134523-00-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=134523-00-5'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=134523-00-5" class="external text external">134523-00-5</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/60823  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/60823'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/60823" class="external text external">60823</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2949  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2949'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2949" class="external text external">2949</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/APRD00055  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/APRD00055'" tppabs="https://www.drugbank.ca/drugs/APRD00055" class="external text external">APRD00055</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.54810.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.54810.html'" tppabs="http://www.chemspider.com/Chemical-Structure.54810.html" class="external text external">54810</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=A0JWA85V8F  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=A0JWA85V8F'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=A0JWA85V8F" class="external text external">A0JWA85V8F</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D07474  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D07474'" tppabs="https://www.kegg.jp/entry/D07474" class="external text external">D07474</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:39548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:39548'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:39548" class="external text external">CHEBI:39548</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1487'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1487" class="external text external">ChEMBL1487</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>117 (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=117  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=117'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=117" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=117&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=117&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=117&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID8029868  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID8029868'" tppabs="https://comptox.epa.gov/dashboard/DTXSID8029868" class="external text external">DTXSID8029868</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.125.464  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.125.464'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.125.464" class="external text external">100.125.464</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>33</sub><span>H</span><sub>35</sub><span>F</span><span>N</span><sub>2</sub><span>O</span><sub>5</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td>558.64<span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29CCn2c%28c%28c%28c2c1ccc%28F%29cc1%29c3ccccc3%29C%28%3DO%29Nc4ccccc4%29C%28C%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29CCn2c%28c%28c%28c2c1ccc%28F%29cc1%29c3ccccc3%29C%28%3DO%29Nc4ccccc4%29C%28C%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29CCn2c%28c%28c%28c2c1ccc%28F%29cc1%29c3ccccc3%29C%28%3DO%29Nc4ccccc4%29C%28C%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:XUKUURHRXDUEBC-KAYWLYCHSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477861573&page2=Atorvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477861573&page2=Atorvastatin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477861573&page2=Atorvastatin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Common side effects include joint pain, diarrhea, heartburn, nausea, and muscle pains.<span class="mw-ref" id="cite_ref-AHFS2018_2-3"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Serious side effects may include rhabdomyolysis, liver problems, and diabetes.<span class="mw-ref" id="cite_ref-AHFS2018_2-4"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Use during pregnancy may harm the baby.<span class="mw-ref" id="cite_ref-AHFS2018_2-5"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Like all statins, atorvastatin works by inhibiting HMG-CoA reductase, an enzyme found in the liver that plays a role in producing <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a>.<span class="mw-ref" id="cite_ref-AHFS2018_2-6"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


<p>Atorvastatin was patented in 1986, and approved for medical use in the United States in 1996.<span class="mw-ref" id="cite_ref-AHFS2018_2-7"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Fis2006_3-0"><a href="#cite_note-Fis2006-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is available as a generic medication and is relatively inexpensive.<span class="mw-ref" id="cite_ref-AHFS2018_2-8"><a href="#cite_note-AHFS2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Hit2014_4-0"><a href="#cite_note-Hit2014-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In 2017, it was the second most prescribed medication in the United States, with more than 104<span class="nowrap"><span>&nbsp;</span></span>million prescriptions.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>The primary uses of atorvastatin is for the treatment of dyslipidemia and the prevention of cardiovascular disease:<span class="mw-ref" id="cite_ref-AHFS_7-0"><a href="#cite_note-AHFS-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Dyslipidemia">Dyslipidemia</h3></summary>
    
<ul><li>Hypercholesterolemia<span class="mw-ref" id="cite_ref-pmid12915827_8-0"><a href="#cite_note-pmid12915827-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> (heterozygous familial and nonfamilial) and mixed dyslipidemia (Fredrickson types IIa and IIb) to reduce total <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a>, LDL-C,<span class="mw-ref" id="cite_ref-Nissen_2006_9-0"><a href="#cite_note-Nissen_2006-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> apo-B,<span class="mw-ref" id="cite_ref-pmid7749881_10-0"><a href="#cite_note-pmid7749881-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> triglycerides<span class="mw-ref" id="cite_ref-pmid8531308_11-0"><a href="#cite_note-pmid8531308-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> levels, and CRP<span class="mw-ref" id="cite_ref-pmid16908955_12-0"><a href="#cite_note-pmid16908955-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> as well as increase HDL levels.</li>
<li>Heterozygous familial hypercholesterolemia<span class="mw-ref" id="cite_ref-pmid12915827_8-1"><a href="#cite_note-pmid12915827-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> in children</li>
<li>Homozygous familial hypercholesterolemia<span class="mw-ref" id="cite_ref-pmid12915827_8-2"><a href="#cite_note-pmid12915827-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid9301631_13-0"><a href="#cite_note-pmid9301631-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>Hypertriglyceridemia (Fredrickson Type IV)</li>
<li>Primary dysbetalipoproteinemia (Fredrickson Type III)</li>
<li>Combined hyperlipidemia<span class="mw-ref" id="cite_ref-AMH_2006_14-0"><a href="#cite_note-AMH_2006-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cardiovascular_disease">Cardiovascular disease</h3></summary>
    
<ul><li>Primary prevention of heart attack, stroke, and need for revascularization procedures in people who have risk factors such as age, smoking, high blood pressure, low HDL-C, and a family history of early heart disease, but have not yet developed evidence of coronary artery disease.<span class="mw-ref" id="cite_ref-Lipitor_label_15-0"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Secondary prevention of myocardial infarction, stroke, unstable angina,<span class="mw-ref" id="cite_ref-pmid12686036_16-0"><a href="#cite_note-pmid12686036-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-pmid12829554_17-0"><a href="#cite_note-pmid12829554-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> and revascularization in people with established coronary artery disease.<span class="mw-ref" id="cite_ref-Wilson_2008_18-0"><a href="#cite_note-Wilson_2008-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-pmid9514454_19-0"><a href="#cite_note-pmid9514454-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></li>
<li>Myocardial infarction and stroke prevention in people with type II diabetes<span class="mw-ref" id="cite_ref-pmid15325833_20-0"><a href="#cite_note-pmid15325833-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-pmid17065671_21-0"><a href="#cite_note-pmid17065671-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-pmid11225965_22-0"><a href="#cite_note-pmid11225965-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></li></ul>

<p>Studies suggest that high-dose statin therapy may play a plaque-stabilizing role in people with acute coronary syndrome and thrombotic stroke.<span class="mw-ref" id="cite_ref-Rosa_501–15_23-0"><a href="#cite_note-Rosa_501–15-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Furie_1994–5_24-0"><a href="#cite_note-Furie_1994–5-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Kidney_disease">Kidney disease</h3></summary>
    
<p>In people with cardiovascular disease, statins including atorvastatin, do not reduce the risk of kidney failure, but have shown to modestly reduce the progressive decline in kidney function and the severity of protein excretion in urine.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Statins, including atorvastatin, before heart surgery does not prevent acute kidney injury.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>

<p>Some statins, including atorvastatin, may help prevent contrast-induced nephropathy in certain groups, such as those with pre-existing kidney impairment.<span class="mw-ref" id="cite_ref-Zhou_2018_27-0"><a href="#cite_note-Zhou_2018-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><span class="mw-ref" id="cite_ref-Fan_2016_28-0"><a href="#cite_note-Fan_2016-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span><span class="mw-ref" id="cite_ref-Cho_2020_29-0"><a href="#cite_note-Cho_2020-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Zhang_2018_30-0"><a href="#cite_note-Zhang_2018-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> There is some evidence to suggest that high-dose statin provides greater benefit compared with regular-dose and low-dose statin in the prevention of contrast-induced acute kidney injury.<span class="mw-ref" id="cite_ref-Zhou_2018_27-1"><a href="#cite_note-Zhou_2018-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><span class="mw-ref" id="cite_ref-Fan_2016_28-1"><a href="#cite_note-Fan_2016-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Administration">Administration</h3></summary>
    
<p>Atorvastatin may be used in combination with bile acid sequestrants and <a href="Ezetimibe.htm" tppabs="https://ptable.com/wiki/compounds/A/Ezetimibe" title="Ezetimibe">ezetimibe</a> to increase the reduction in cholesterol levels. However, it is not recommended to combine statin medication treatment with certain other cholesterol-lowering medications, particularly fibrates, because this may increase the risk of myopathy-related adverse effects.<span class="mw-ref" id="cite_ref-Lipitor_label_15-1"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>While many statin medications should be administered at bedtime for optimal effect, atorvastatin can be dosed at any time of day, as long as it is continually dosed once daily at the same time.<span class="mw-ref" id="cite_ref-pmid11368702_31-0"><a href="#cite_note-pmid11368702-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid15249516_32-0"><a href="#cite_note-pmid15249516-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Specific_populations">Specific populations</h3></summary>
    
<ul><li>Geriatric: Plasma concentrations of atorvastatin in healthy elderly subjects are higher than those in young adults, and clinical data suggests a greater degree of LDL-lowering at any dose for people in the population as compared to young adults.<span class="mw-ref" id="cite_ref-Lipitor_label_15-2"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Pediatric: Pharmacokinetic data is not available for this population.<span class="mw-ref" id="cite_ref-Lipitor_label_15-3"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Gender: Plasma concentrations are generally higher in women than in men, but there is no clinically significant difference in the extent of LDL reduction between men and women.<span class="mw-ref" id="cite_ref-Lipitor_label_15-4"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Kidney impairment: Kidney disease has no influence on plasma concentrations of atorvastatin and dosing need not be adjusted in these people.<span class="mw-ref" id="cite_ref-Lipitor_label_15-5"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Hemodialysis: Hemodialysis will not significantly alter medication levels or change clinical effect of atorvastatin.<span class="mw-ref" id="cite_ref-Lipitor_label_15-6"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Hepatic impairment: In people with chronic alcoholic liver disease, levels of atorvastatin may be significantly increased depending upon the extent of liver disease.<span class="mw-ref" id="cite_ref-Lipitor_label_15-7"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li></ul>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<ul><li>Active liver disease: cholestasis, hepatic encephalopathy, hepatitis, and jaundice</li>
<li>Unexplained elevations in AST or ALT levels</li>
<li>Pregnancy: Atorvastatin may cause fetal harm by affecting serum cholesterol and triglyceride levels, which are essential for fetal development.<span class="mw-ref" id="cite_ref-Lipitor_label_15-8"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Breastfeeding: Small amounts of other statin medications have been found to pass into breast milk, although atorvastatin has not been studied, specifically.<span class="mw-ref" id="cite_ref-Lipitor_label_15-9"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Due to risk of disrupting a breastfeeding infant's metabolism of lipids, atorvastatin is not regarded as compatible with breastfeeding.<span class="mw-ref" id="cite_ref-LactMed_Atorvastatin_33-0"><a href="#cite_note-LactMed_Atorvastatin-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></li>
<li>Markedly elevated CPK levels or if a myopathy is suspected or diagnosed after dosing of atorvastatin has begun. Very rarely, atorvastatin may cause rhabdomyolysis,<span class="mw-ref" id="cite_ref-pmid16765141_34-0"><a href="#cite_note-pmid16765141-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> and it may be very serious leading to acute kidney injury due to myoglobinuria. If rhabdomyolysis is suspected or diagnosed, atorvastatin therapy should be discontinued immediately.<span class="mw-ref" id="cite_ref-pmid12036392_35-0"><a href="#cite_note-pmid12036392-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The likelihood of developing a myopathy is increased by the co-administration of <a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclosporine" title="Cyclosporine" class="mw-redirect">cyclosporine</a>, fibric acid derivatives, <a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">erythromycin</a>, <a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">niacin</a>, and <a href="Azole.htm" tppabs="https://ptable.com/wiki/compounds/A/Azole" title="Azole">azole</a> antifungals.<span class="mw-ref" id="cite_ref-Lipitor_label_15-10"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Major">Major</h3></summary>
    
<ul><li>Type 2 diabetes mellitus, an uncommon class effect of all statins.<span class="mw-ref" id="cite_ref-FDA_2014_statins_36-0"><a href="#cite_note-FDA_2014_statins-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-webmd_2012_diabetes_37-0"><a href="#cite_note-webmd_2012_diabetes-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></li>
<li>Myopathy with elevation of creatine kinase (CK, aka CPK)<span class="mw-ref" id="cite_ref-pmid8463436_39-0"><a href="#cite_note-pmid8463436-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> and rhabdomyolysis are the most serious side effects, occurring rarely at a rate of 2.3 to 9.1 per 10,000 person-years among people taking atorvastatin.<span class="mw-ref" id="cite_ref-AMH_2006_14-1"><a href="#cite_note-AMH_2006-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-Lipitor_label_15-11"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> As mentioned previously, atorvastatin should be discontinued immediately if this occurs.</li>
<li>Persistent liver enzyme abnormalities (elevations in hepatic transaminases) have been documented.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> Elevations threefold greater than normal were recorded in 0.5% of people treated with atorvastatin 10<span>&nbsp;</span>mg-80<span>&nbsp;</span>mg rather than placebo.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> It is recommended that hepatic function be assessed with laboratory tests before beginning atorvastatin treatment and repeated as clinically indicated thereafter. If evidence of serious liver injury occurs while a person is taking atorvastatin, it should be discontinued and not restarted until the etiology of the person's liver dysfunction is defined. If no other cause is found, atorvastatin should be discontinued permanently.<span class="mw-ref" id="cite_ref-Lipitor_label_15-12"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Common">Common</h3></summary>
    
<p>The following have been shown to occur in 1–10% of people taking atorvastatin in clinical trials:</p>
<ul><li>Joint pain<span class="mw-ref" id="cite_ref-Lipitor_label_15-13"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Loose stools<span class="mw-ref" id="cite_ref-Lipitor_label_15-14"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Indigestion<span class="mw-ref" id="cite_ref-Lipitor_label_15-15"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Muscle pain<span class="mw-ref" id="cite_ref-Lipitor_label_15-16"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Nausea<span class="mw-ref" id="cite_ref-Lipitor_label_15-17"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Hyperglycemia High-dose atorvastatin has also been associated with worsening blood sugar control.<span class="mw-ref" id="cite_ref-Mayo_Clinic_Staff_43-0"><a href="#cite_note-Mayo_Clinic_Staff-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-pmid20507274_44-0"><a href="#cite_note-pmid20507274-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other">Other</h3></summary>
    
<p>In 2014, the US Food and Drug Administration (FDA) reported memory loss, forgetfulness and confusion with all statin products including atorvastatin. The symptoms were not serious, and they were rare and reversible on cessation of treatment with the medication.<span class="mw-ref" id="cite_ref-FDA_2014_statins_36-1"><a href="#cite_note-FDA_2014_statins-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>

<p>A few cases of pancreatitis have been associated with atorvastatin.<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Interactions">Interactions</h3></summary>
    
<p>Interactions with clofibrate, fenofibrate, gemfibrozil, which are fibrates used in accessory therapy in many forms of hypercholesterolemia, usually in combination with statins, increase the risk of myopathy and rhabdomyolysis.<span class="mw-ref" id="cite_ref-pmid8463436_39-1"><a href="#cite_note-pmid8463436-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-pmid18158710_46-0"><a href="#cite_note-pmid18158710-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-Graham2004_47-0"><a href="#cite_note-Graham2004-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>

<p>Co-administration of atorvastatin with one of CYP3A4 inhibitors such as <a href="Itraconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Itraconazole" title="Itraconazole">itraconazole</a>,<span class="mw-ref" id="cite_ref-pmid11061579_48-0"><a href="#cite_note-pmid11061579-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> <a href="Telithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Telithromycin" title="Telithromycin">telithromycin</a>, and <a href="Voriconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Voriconazole" title="Voriconazole">voriconazole</a>, may increase serum concentrations of atorvastatin, which may lead to adverse reactions. This is less likely to happen with other CYP3A4 inhibitors such as <a href="Diltiazem.htm" tppabs="https://ptable.com/wiki/compounds/A/Diltiazem" title="Diltiazem">diltiazem</a>, <a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">erythromycin</a>, <a href="Fluconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluconazole" title="Fluconazole">fluconazole</a>, <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">ketoconazole</a>, <a href="Clarithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clarithromycin" title="Clarithromycin">clarithromycin</a>, <a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclosporine" title="Cyclosporine" class="mw-redirect">cyclosporine</a>, protease inhibitors, or <a href="Verapamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Verapamil" title="Verapamil">verapamil</a>,<span class="mw-ref" id="cite_ref-pmid17178259_49-0"><a href="#cite_note-pmid17178259-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> and only rarely with other CYP3A4 inhibitors, such as <a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">amiodarone</a> and <a href="Aprepitant.htm" tppabs="https://ptable.com/wiki/compounds/A/Aprepitant" title="Aprepitant">aprepitant</a>.<span class="mw-ref" id="cite_ref-pmid12036392_35-1"><a href="#cite_note-pmid12036392-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> Often, <a href="Bosentan.htm" tppabs="https://ptable.com/wiki/compounds/A/Bosentan" title="Bosentan">bosentan</a>, <a href="Fosphenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosphenytoin" title="Fosphenytoin">fosphenytoin</a>, and <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">phenytoin</a>, which are CYP3A4 inducers, can decrease the plasma concentrations of atorvastatin. Only rarely, though, <a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">barbiturates</a>, <a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">carbamazepine</a>, <a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">efavirenz</a>, <a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">nevirapine</a>, <a href="Oxcarbazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxcarbazepine" title="Oxcarbazepine">oxcarbazepine</a>, <a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">rifampin</a>, and rifamycin,<span class="mw-ref" id="cite_ref-pmid16084850_50-0"><a href="#cite_note-pmid16084850-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> which are also CYP3A4 inducers, can decrease the plasma concentrations of atorvastatin. Oral contraceptives increased AUC values for <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a> and ethinylestradiol; these increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin.<span class="mw-ref" id="cite_ref-Lipitor_label_15-18"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Antacids can rarely decrease the plasma concentrations of statin medications, but do not affect the LDL-C-lowering efficacy.<span class="mw-ref" id="cite_ref-pmid15901588_51-0"><a href="#cite_note-pmid15901588-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>

<p><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin</a> also is proved to increase the risk of myopathy or rhabdomyolysis.<span class="mw-ref" id="cite_ref-pmid12036392_35-2"><a href="#cite_note-pmid12036392-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>

<p>Some statins may also alter the concentrations of other medications, such as <a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">warfarin</a> or <a href="Digoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digoxin" title="Digoxin">digoxin</a>, leading to alterations in effect or a requirement for clinical monitoring.<span class="mw-ref" id="cite_ref-pmid12036392_35-3"><a href="#cite_note-pmid12036392-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The increase in digoxin levels due to atorvastatin is a 1.2 fold elevation in the area under the curve (AUC), resulting in a minor drug-drug interaction. The American Heart Association states that the combination of digoxin and atorvastatin is reasonable.<span class="mw-ref" id="cite_ref-Wiggins_et_al_52-0"><a href="#cite_note-Wiggins_et_al-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> In contrast to some other statins, atorvastatin does not interact with warfarin concentrations in a clinically meaningful way (similar to pitavastatin).<span class="mw-ref" id="cite_ref-Wiggins_et_al_52-1"><a href="#cite_note-Wiggins_et_al-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>

<p><a href="Vitamin_D.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_D" title="Vitamin D">Vitamin D</a> supplementation lowers atorvastatin and active metabolite concentrations, yet synergistically reduces LDL and total <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a> concentrations.<span class="mw-ref" id="cite_ref-pmid18754003_53-0"><a href="#cite_note-pmid18754003-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> Grapefruit juice components are known inhibitors of intestinal CYP3A4.</p>

<p>Drinking grapefruit juice with atorvastatin may cause an increase in C<sub>max</sub> and area under the curve (AUC). This finding initially gave rise to concerns of toxicity, and in 2000, it was recommended that people taking atorvastatin should not consume grapefruit juice "in an unsupervised manner."<span class="mw-ref" id="cite_ref-Kane2000_54-0"><a href="#cite_note-Kane2000-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> Small studies (using mostly young participants) examining the effects of grapefruit juice consumption on mainly lower doses of atorvastatin have shown that grapefruit juice increases blood levels of atorvastatin, which could increase the risk of adverse effects.<span class="mw-ref" id="cite_ref-:1_55-0"><a href="#cite_note-:1-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span><span class="mw-ref" id="cite_ref-:2_56-0"><a href="#cite_note-:2-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-:3_57-0"><a href="#cite_note-:3-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> No studies assessing the impact of grapefruit juice consumption have included participants taking the highest dose of atorvastatin (80<span>&nbsp;</span>mg daily),<span class="mw-ref" id="cite_ref-:1_55-1"><a href="#cite_note-:1-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span><span class="mw-ref" id="cite_ref-:2_56-1"><a href="#cite_note-:2-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-:3_57-1"><a href="#cite_note-:3-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> which is often prescribed for people with a history of cardiovascular disease (such as heart attack or ischaemic stroke) or in people at high risk of cardiovascular disease. People taking atorvastatin should consult with their doctor or pharmacist before consuming grapefruit juice, as the effects of grapefruit juice consumption on atorvastatin will vary according to factors such as the amount and frequency of juice consumption in addition to differences in juice components, quality and method of juice preparation between different batches or brands.<span class="mw-ref" id="cite_ref-58"><a href="#cite_note-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>

<p>A few cases of myopathy have been reported when atorvastatin is given with <a href="Colchicine.htm" tppabs="https://ptable.com/wiki/compounds/A/Colchicine" title="Colchicine">colchicine</a>.<span class="mw-ref" id="cite_ref-Lipitor_label_15-19"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    


<p>As with other statins, atorvastatin is a competitive inhibitor of HMG-CoA reductase. Unlike most others, however, it is a completely synthetic compound. HMG-CoA reductase catalyzes the reduction of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) to mevalonate, which is the rate-limiting step in hepatic <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a> biosynthesis. Inhibition of the enzyme decreases <i>de novo</i> cholesterol synthesis, increasing expression of low-density lipoprotein receptors (LDL receptors) on hepatocytes. This increases LDL uptake by the hepatocytes, decreasing the amount of LDL-cholesterol in the blood. Like other statins, atorvastatin also reduces blood levels of triglycerides and slightly increases levels of HDL-cholesterol.</p>

<p>In people with acute coronary syndrome, high-dose atorvastatin treatment may play a plaque-stabilizing role.<span class="mw-ref" id="cite_ref-:0_59-0"><a href="#cite_note-:0-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-Rosa_501–15_23-1"><a href="#cite_note-Rosa_501–15-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> At high doses, statins have anti-inflammatory effects, incite reduction of the necrotic plaque core, and improve endothelial function, leading to plaque stabilization and, sometimes, plaque regression.<span class="mw-ref" id="cite_ref-Rosa_501–15_23-2"><a href="#cite_note-Rosa_501–15-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-:0_59-1"><a href="#cite_note-:0-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> There is a similar thought process with using high-dose statins to prevent recurrence of thrombotic stroke.<span class="mw-ref" id="cite_ref-Furie_1994–5_24-1"><a href="#cite_note-Furie_1994–5-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<p>The liver is the primary site of action of atorvastatin, as this is the principal site of both cholesterol synthesis and LDL clearance. It is the dosage of atorvastatin, rather than systemic medication concentration, which correlates with extent of LDL-C reduction.<span class="mw-ref" id="cite_ref-Lipitor_label_15-20"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> In a Cochrane systematic review the dose-related magnitude of atorvastatin on blood lipids was determined. Over the dose range of 10 to 80<span>&nbsp;</span>mg/day total cholesterol was reduced by 27.0% to 37.9%, LDL cholesterol by 37.1% to 51.7% and triglycerides by 18.0% to 28.3%.<span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    



    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Absorption">Absorption</h3></summary>
    
<p>Atorvastatin undergoes rapid absorption when taken orally, with an approximate time to maximum plasma concentration (T<sub>max</sub>) of 1–2 h. The absolute bioavailability of the medication is about 14%, but the systemic availability for HMG-CoA reductase activity is approximately 30%. Atorvastatin undergoes high intestinal clearance and first-pass metabolism, which is the main cause for the low systemic availability. Administration of atorvastatin with food produces a 25% reduction in C<sub>max</sub> (rate of absorption) and a 9% reduction in AUC (extent of absorption), although food does not affect the plasma LDL-C-lowering efficacy of atorvastatin. Evening dose administration is known to reduce the C<sub>max</sub> and AUC by 30% each. However, time of administration does not affect the plasma LDL-C-lowering efficacy of atorvastatin.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Distribution">Distribution</h3></summary>
    
<p>The mean volume of distribution of atorvastatin is approximately 381 L. It is highly protein bound (≥98%), and studies have shown it is likely secreted into human breastmilk.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Metabolism">Metabolism</h3></summary>
    
<p>Atorvastatin metabolism is primarily through cytochrome P450 3A4 hydroxylation to form active ortho- and parahydroxylated metabolites, as well as various beta-oxidation metabolites. The ortho- and parahydroxylated metabolites are responsible for 70% of systemic HMG-CoA reductase activity. The ortho-hydroxy metabolite undergoes further metabolism via glucuronidation. As a substrate for the CYP3A4 isozyme, it has shown susceptibility to inhibitors and inducers of CYP3A4 to produce increased or decreased plasma concentrations, respectively. This interaction was tested <i>in vitro</i> with concurrent administration of <a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">erythromycin</a>, a known CYP3A4 isozyme inhibitor, which resulted in increased plasma concentrations of atorvastatin. It is also an inhibitor of cytochrome 3A4.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Excretion">Excretion</h3></summary>
    
<p>Atorvastatin is primarily eliminated via hepatic biliary excretion, with less than 2% recovered in the urine. Bile elimination follows hepatic and/or extrahepatic metabolism. There does not appear to be any entero-hepatic recirculation. Atorvastatin has an approximate elimination half-life of 14 hours. Noteworthy, the HMG-CoA reductase inhibitory activity appears to have a half-life of 20–30 hours, which is thought to be due to the active metabolites. Atorvastatin is also a substrate of the intestinal P-glycoprotein efflux transporter, which pumps the medication back into the intestinal lumen during medication absorption.<span class="mw-ref" id="cite_ref-pmid12036392_35-4"><a href="#cite_note-pmid12036392-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>

<p>In hepatic insufficiency, plasma concentrations of atorvastatin are significantly affected by concurrent liver disease. People with Child-Pugh Stage A liver disease show a four-fold increase in both C<sub>max</sub> and AUC. People with Child Pugh stage B liver disease show a 16-fold increase in C<sub>max</sub> and an 11-fold increase in AUC.</p>

<p>Geriatric people (&gt;65<span class="nowrap"><span>&nbsp;</span></span>years old) exhibit altered pharmacokinetics of atorvastatin compared to young adults, with mean AUC and C<sub>max</sub> values that are 40% and 30% higher, respectively. Additionally, healthy elderly people show a greater pharmacodynamic response to atorvastatin at any dose; therefore, this population may have lower effective doses.<span class="mw-ref" id="cite_ref-Lipitor_label_15-21"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacogenetics">Pharmacogenetics</h2></summary>
    
<p>Several genetic polymorphisms may be linked to an increase in statin-related side effects with single nucleotide polymorphisms (SNPs) in the SLCO1B1 gene showing a 45 fold higher incidence of statin related myopathy<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> than patients without the polymorphism.</p>

<p>There are several studies showing genetic variants and variable response to atorvastatin,.<span class="mw-ref" id="cite_ref-pmid22368281_62-0"><a href="#cite_note-pmid22368281-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Thompson_JF_63-0"><a href="#cite_note-Thompson_JF-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> The polymorphisms that showed genome wide significance in Caucasian population were the SNPs in the apoE region; rs445925,<span class="mw-ref" id="cite_ref-pmid22368281_62-1"><a href="#cite_note-pmid22368281-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> rs7412,<span class="mw-ref" id="cite_ref-pmid22368281_62-2"><a href="#cite_note-pmid22368281-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Thompson_JF_63-1"><a href="#cite_note-Thompson_JF-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> rs429358<span class="mw-ref" id="cite_ref-Thompson_JF_63-2"><a href="#cite_note-Thompson_JF-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> and rs4420638<span class="mw-ref" id="cite_ref-pmid22368281_62-3"><a href="#cite_note-pmid22368281-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> which showed variable LDL-c response depending on the genotype when treated with atorvastatin.<span class="mw-ref" id="cite_ref-pmid22368281_62-4"><a href="#cite_note-pmid22368281-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Thompson_JF_63-3"><a href="#cite_note-Thompson_JF-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Another genetic variant that showed genome wide significance in Caucasians was the SNP rs10455872 in the LPA gene that lead to higher Lp(a) levels which cause an apparent lower LDL-c response to atorvastatin.<span class="mw-ref" id="cite_ref-pmid22368281_62-5"><a href="#cite_note-pmid22368281-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> These studies were in Caucasian population, more research with a large cohort need to be conducted in different ethnicities to identify more polymorphisms that can affect atorvastatin pharmacokinetics and treatment response. 
<span class="mw-ref" id="cite_ref-pmid22368281_62-6"><a href="#cite_note-pmid22368281-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Bruce Roth, who was hired by Warner-Lambert as a chemist in 1982, had synthesized an "experimental compound" codenamed CI 981 – later called atorvastatin.<span class="mw-ref" id="cite_ref-Fortune_2003_64-0"><a href="#cite_note-Fortune_2003-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span><span class="mw-ref" id="cite_ref-FT_nov_2009_65-0"><a href="#cite_note-FT_nov_2009-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> It was first made in August 1985.<span class="mw-ref" id="cite_ref-Roth_2002_66-0"><a href="#cite_note-Roth_2002-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-Fortune_2003_64-1"><a href="#cite_note-Fortune_2003-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span><span class="mw-ref" id="cite_ref-US4681893_67-0"><a href="#cite_note-US4681893-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-History_Parke-Davis_68-0"><a href="#cite_note-History_Parke-Davis-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-NYT_2000_69-0"><a href="#cite_note-NYT_2000-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Warner-Lambert management was concerned that atorvastatin was a me-too version of rival Merck &amp; Co.'s orphan drug lovastatin (brand name <a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevacor" title="Mevacor" class="mw-redirect">Mevacor</a>). Mevacor, which was first marketed in 1987, was the industry's first statin and Merck's synthetic version – <a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">simvastatin</a> – was in the advanced stages of development.<span class="mw-ref" id="cite_ref-FT_nov_2009_65-1"><a href="#cite_note-FT_nov_2009-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> Nevertheless, Bruce Roth and his bosses, Roger Newton and Ronald Cresswell, in 1985, convinced company executives to move the compound into expensive clinical trials. Early results comparing atorvastatin to simvastatin demonstrated that atorvastatin appeared more potent and with fewer side effects.<span class="mw-ref" id="cite_ref-FT_nov_2009_65-2"><a href="#cite_note-FT_nov_2009-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></p>

<p>In 1994, the findings of a Merck-funded study were published in <i>The Lancet</i> concluding the efficacy of statins in lowering cholesterol proving for the first time not only that a "statin reduced 'bad' LDL cholesterol but also that it led to a sharp drop in fatal heart attacks among people with heart disease."<span class="mw-ref" id="cite_ref-FT_nov_2009_65-3"><a href="#cite_note-FT_nov_2009-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-Lancet_1994_scandinavia_70-0"><a href="#cite_note-Lancet_1994_scandinavia-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></p>

<p>In 1996, Warner-Lambert entered into a co-marketing agreement with Pfizer to sell Lipitor, and in 2000, Pfizer acquired Warner-Lambert for $90.2<span class="nowrap"><span>&nbsp;</span></span>billion.<span class="mw-ref" id="cite_ref-WSJ_blockbuster_2000_71-0"><a href="#cite_note-WSJ_blockbuster_2000-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span><span class="mw-ref" id="cite_ref-Roth_2002_66-1"><a href="#cite_note-Roth_2002-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-US4681893_67-1"><a href="#cite_note-US4681893-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-History_Parke-Davis_68-1"><a href="#cite_note-History_Parke-Davis-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> Lipitor was on the market by 1996.<span class="mw-ref" id="cite_ref-NYT_2000_69-1"><a href="#cite_note-NYT_2000-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span><span class="mw-ref" id="cite_ref-FDA_Lipitor_72-0"><a href="#cite_note-FDA_Lipitor-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> By 2003, Lipitor had become the best selling pharmaceutical in the United States.<span class="mw-ref" id="cite_ref-Fortune_2003_64-2"><a href="#cite_note-Fortune_2003-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> From 1996 to 2012, under the trade name Lipitor, atorvastatin became the world's best-selling medication of all time, with more than $125<span class="nowrap"><span>&nbsp;</span></span>billion in sales over approximately 14.5<span class="nowrap"><span>&nbsp;</span></span>years.<span class="mw-ref" id="cite_ref-Crain_2011_73-0"><a href="#cite_note-Crain_2011-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years."<span class="mw-ref" id="cite_ref-Crain_2011_73-1"><a href="#cite_note-Crain_2011-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span></p>

<p>Pfizer's patent on atorvastatin expired in November 2011.<span class="mw-ref" id="cite_ref-CNN_Wire_Staff_74-0"><a href="#cite_note-CNN_Wire_Staff-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-CNN_Wire_Staff_74-1"><a href="#cite_note-CNN_Wire_Staff-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cost">Cost</h3></summary>
    
<p>Atorvastatin is relatively inexpensive.<span class="mw-ref" id="cite_ref-Hit2014_4-1"><a href="#cite_note-Hit2014-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In the United States, the wholesale cost per month is about US$3.80 as of 2018.<span class="mw-ref" id="cite_ref-75"><a href="#cite_note-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> In the United Kingdom, it costs the NHS about £0.70 per month as of 2018.<span class="mw-ref" id="cite_ref-BNF76_76-0"><a href="#cite_note-BNF76-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> Under provisions of the Patient Protection and Affordable Care Act (PPACA) in the United States, there is no cost for adults aged 40–75 years for atorvastatin 10<span>&nbsp;</span>mg and 20<span>&nbsp;</span>mg based on United States Preventive Services Task Force (USPSTF) recommendations.<span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span><span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Chemical_synthesis">Chemical synthesis</h3></summary>
    

<div class="thumb tright"><div class="thumbinner" style="width:602px"><img src="../I/m/Atorvastatin_synthesis_stereocenter_commercial.png" tppabs="https://ptable.com/wiki/compounds/I/m/Atorvastatin_synthesis_stereocenter_commercial.png" data-file-width="2095" data-file-height="442" data-file-type="bitmap" height="127" width="600"><div class="thumbcaption" style="text-align: left">Atorvastatin synthesis in commercial production (process) chemistry. The key step of establishing this medication's stereocenters, through initial use of an inexpensive natural product (chiral pool approach).</div></div></div>

<div class="thumb tright"><div class="thumbinner" style="width:602px"><img src="../I/m/Atorvastatin_synthesis_stereocenter_firstdiscovery.png" tppabs="https://ptable.com/wiki/compounds/I/m/Atorvastatin_synthesis_stereocenter_firstdiscovery.png" data-file-width="2365" data-file-height="679" data-file-type="bitmap" height="172" width="600"><div class="thumbcaption" style="text-align: left">Atorvastatin synthesis during discovery chemistry. The key step of establishing stereocenters, using of a chiral ester auxiliary approach.</div></div></div>

<p>The first synthesis of atorvastatin at Parke-Davis that occurred during drug discovery was racemic followed by chiral chromatographic separation of the enantiomers. An early enantioselective route to atorvastatin made use of an ester chiral auxiliary to set the stereochemistry of the first of the two alcohol functional groups via a diastereoselective aldol reaction.<span class="mw-ref" id="cite_ref-Roth_2002_66-2"><a href="#cite_note-Roth_2002-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-79"><a href="#cite_note-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span></p>

<p>Once the compound entered pre-clinical development, process chemistry developed a cost-effective and scalable synthesis.<span class="mw-ref" id="cite_ref-Roth_2002_66-3"><a href="#cite_note-Roth_2002-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span> In atorvastatin's case, a key element of the overall synthesis was ensuring stereochemical purity in the final drug substance, and hence establishing the first stereocenter became a key aspect of the overall design. The final commercial production of atorvastatin relied on a chiral pool approach, where the stereochemistry of the first alcohol functional group was carried into the synthesis—through the choice of <a href="Erythorbic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythorbic_acid" title="Erythorbic acid">isoascorbic acid</a>, an inexpensive and easily sourced plant-derived natural product.<span class="mw-ref" id="cite_ref-Roth_2002_66-4"><a href="#cite_note-Roth_2002-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-80"><a href="#cite_note-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Formulations">Formulations</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Atorvastatin40mg.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Atorvastatin40mg.jpg" data-file-width="640" data-file-height="420" data-file-type="bitmap" height="144" width="220"><div class="thumbcaption" style="text-align: left">Pack and tablet of atorvastatin (Lipitor) 40mg</div></div></div>

<p>Atorvastatin calcium tablets are marketed by Pfizer under the trade name Lipitor<span class="mw-ref" id="cite_ref-MPR_81-0"><a href="#cite_note-MPR-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span> for oral administration. Tablets are white, elliptical, and film-coated. Pfizer also packages the medication in combination with other medications, such as atorvastatin/amlodipine.<span class="mw-ref" id="cite_ref-NewsMed_82-0"><a href="#cite_note-NewsMed-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span> Pfizer recommends that people do not break tablets in half to take half-doses, even when this is recommended by their doctors.<span class="mw-ref" id="cite_ref-Lipitor_label_15-22"><a href="#cite_note-Lipitor_label-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generics">Generics</h3></summary>
    

<p>Pfizer's U.S. patent on Lipitor expired on 30 November 2011.<span class="mw-ref" id="cite_ref-83"><a href="#cite_note-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> Initially, generic atorvastatin was manufactured only by Watson Pharmaceuticals and India's Ranbaxy Laboratories. Prices for the generic version did not drop to the level of other generics—$10 or less for a month's supply—until other manufacturers began to supply the medication in May 2012.<span class="mw-ref" id="cite_ref-84"><a href="#cite_note-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span></p>

<p>In other countries, atorvastatin calcium is made in tablet form by generic medication makers under various brand names including Atoris, Atorlip, Atorva, Atorvastatin Teva, Atorvastatina Parke-Davis, Avas, Cardyl, Liprimar, Litorva, Mactor, Orbeos, Prevencor, Sortis, Stator, Tahor, Torid, Torvacard, Torvast, Totalip, Tulip, Xarator, and Zarator.<span class="mw-ref" id="cite_ref-Drugs.com_2020_85-0"><a href="#cite_note-Drugs.com_2020-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-86"><a href="#cite_note-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span>  Pfizer also makes its own generic version under the name Zarator.<span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Medication_recalls">Medication recalls</h3></summary>
    
<p>On 9 November 2012, Indian drugmaker Ranbaxy Laboratories Ltd. voluntarily recalled 10-, 20- and 40-mg doses of its generic version of atorvastatin in the United States.<span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span><span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> The lots of atorvastatin, packaged in bottles of 90 and 500 tablets, were recalled due to possible contamination with very small glass particles similar to the size of a grain of sand (less than 1<span class="nowrap"><span>&nbsp;</span></span>mm in size). The FDA received no reports of injury from the contamination.<span class="mw-ref" id="cite_ref-90"><a href="#cite_note-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> Ranbaxy also issued recalls of bottles of 10-milligram tablets in August 2012 and March 2014, due to concerns that the bottles might contain larger, 20-milligram tablets and thus cause potential dosing errors.<span class="mw-ref" id="cite_ref-91"><a href="#cite_note-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span><span class="mw-ref" id="cite_ref-Washington_Post_2014_92-0"><a href="#cite_note-Washington_Post_2014-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/atorvastatin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/atorvastatin.html'" tppabs="https://www.drugs.com/pregnancy/atorvastatin.html" class="external text external">"Atorvastatin (Lipitor) Use During Pregnancy"</a>. <i>Drugs.com</i>. 3 February 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2020</span>.</cite></span></li><li id="cite_note-AHFS2018-2"> <span id="mw-reference-text-cite_note-AHFS2018-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/atorvastatin-calcium.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/atorvastatin-calcium.html'" tppabs="https://www.drugs.com/monograph/atorvastatin-calcium.html" class="external text external">"Atorvastatin Calcium Monograph for Professionals"</a>. <i>Drugs.com</i>. AHFS<span class="reference-accessdate">. Retrieved <span class="nowrap">23 December</span> 2018</span>.</cite></span></li><li id="cite_note-Fis2006-3"> <span id="mw-reference-text-cite_note-Fis2006-3" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer J, Ganellin CR (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA473'" tppabs="https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA473" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>473. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-Hit2014-4"> <span id="mw-reference-text-cite_note-Hit2014-4" class="mw-reference-text"><cite id="CITEREFHitchingsLonsdaleBurrageBaker2014" class="citation book cs1">Hitchings A, Lonsdale D, Burrage D, Baker E (2014). <a href="javascript:if(confirm('https://www.google.com/books/edition/The_Top_100_Drugs_e_book/oeYjAwAAQBAJ?hl=en&gbpv=1&dq=Atorvastatin+inexpensive&pg=PA197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/books/edition/The_Top_100_Drugs_e_book/oeYjAwAAQBAJ?hl=en&gbpv=1&dq=Atorvastatin+inexpensive&pg=PA197'" tppabs="https://www.google.com/books/edition/The_Top_100_Drugs_e_book/oeYjAwAAQBAJ?hl=en&gbpv=1&dq=Atorvastatin+inexpensive&pg=PA197" class="external text external"><i>The Top 100 Drugs e-book: Clinical Pharmacology and Practical Prescribing</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>197. ISBN<span>&nbsp;</span><bdi>978-0-7020-5515-7</bdi>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2020</span>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Atorvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Atorvastatin'" tppabs="https://clincalc.com/DrugStats/Drugs/Atorvastatin" class="external text external">"Atorvastatin - Drug Usage Statistics"</a>. <i>ClinCalc</i>. 23 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">7 April</span> 2020</span>.</cite></span></li><li id="cite_note-AHFS-7"> <span id="mw-reference-text-cite_note-AHFS-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/atorvastatin-calcium.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/atorvastatin-calcium.html'" tppabs="https://www.drugs.com/monograph/atorvastatin-calcium.html" class="external text external">"Atorvastatin Calcium"</a>. American Society of Health-System Pharmacists<span class="reference-accessdate">. Retrieved <span class="nowrap">3 April</span> 2011</span>.</cite></span></li><li id="cite_note-pmid12915827-8"> <span id="mw-reference-text-cite_note-pmid12915827-8" class="mw-reference-text"><cite id="CITEREFMcCrindleOseMarais2003" class="citation journal cs1">McCrindle BW, Ose L, Marais AD (July 2003). "Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial". <i>The Journal of Pediatrics</i>. <b>143</b> (1): 74–80. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0022-3476%2803%2900186-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0022-3476%2803%2900186-0'" tppabs="https://doi.org/10.1016%2FS0022-3476%2803%2900186-0" class="external text external">10.1016/S0022-3476(03)00186-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12915827  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12915827'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12915827" class="external text external">12915827</a>.</cite></span></li><li id="cite_note-Nissen_2006-9"> <span id="mw-reference-text-cite_note-Nissen_2006-9" class="mw-reference-text"><cite id="CITEREFNissenNichollsSipahiLibby2006" class="citation journal cs1">Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM,  et al. (April 2006). <a href="javascript:if(confirm('https://doi.org/10.1001/jama.295.13.jpc60002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/jama.295.13.jpc60002'" tppabs="https://doi.org/10.1001/jama.295.13.jpc60002" class="external text external">"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial"</a>. <i>JAMA</i>. <b>295</b> (13): 1556–65. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.295.13.jpc60002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.295.13.jpc60002'" tppabs="https://doi.org/10.1001%2Fjama.295.13.jpc60002" class="external text external">10.1001/jama.295.13.jpc60002</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16533939  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16533939'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16533939" class="external text external">16533939</a>.</cite></span></li><li id="cite_note-pmid7749881-10"> <span id="mw-reference-text-cite_note-pmid7749881-10" class="mw-reference-text"><cite id="CITEREFNawrockiWeissDavidsonSprecher1995" class="citation journal cs1">Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien PJ,  et al. (May 1995). "Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor". <i>Arteriosclerosis, Thrombosis, and Vascular Biology</i>. <b>15</b> (5): 678–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1161%2F01.ATV.15.5.678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2F01.ATV.15.5.678'" tppabs="https://doi.org/10.1161%2F01.ATV.15.5.678" class="external text external">10.1161/01.ATV.15.5.678</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7749881  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7749881'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7749881" class="external text external">7749881</a>.</cite></span></li><li id="cite_note-pmid8531308-11"> <span id="mw-reference-text-cite_note-pmid8531308-11" class="mw-reference-text"><cite id="CITEREFBakker-ArkemaDavidsonGoldsteinDavignon1996" class="citation journal cs1">Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR,  et al. (January 1996). "Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia". <i>JAMA</i>. <b>275</b> (2): 128–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.1996.03530260042029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.1996.03530260042029'" tppabs="https://doi.org/10.1001%2Fjama.1996.03530260042029" class="external text external">10.1001/jama.1996.03530260042029</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8531308  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8531308'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8531308" class="external text external">8531308</a>.</cite></span></li><li id="cite_note-pmid16908955-12"> <span id="mw-reference-text-cite_note-pmid16908955-12" class="mw-reference-text"><cite id="CITEREFOzakiKuboImakiShinagawa2006" class="citation journal cs1">Ozaki K, Kubo T, Imaki R, Shinagawa H, Fukaya H, Ohtaki K,  et al. (August 2006). <a href="javascript:if(confirm('https://doi.org/10.5551/jat.13.216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5551/jat.13.216'" tppabs="https://doi.org/10.5551/jat.13.216" class="external text external">"The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia"</a>. <i>Journal of Atherosclerosis and Thrombosis</i>. <b>13</b> (4): 216–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.5551%2Fjat.13.216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5551%2Fjat.13.216'" tppabs="https://doi.org/10.5551%2Fjat.13.216" class="external text external">10.5551/jat.13.216</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16908955  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16908955'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16908955" class="external text external">16908955</a>.</cite></span></li><li id="cite_note-pmid9301631-13"> <span id="mw-reference-text-cite_note-pmid9301631-13" class="mw-reference-text"><cite id="CITEREFMaraisFirthBatemanByrnes1997" class="citation journal cs1">Marais AD, Firth JC, Bateman ME, Byrnes P, Martens C, Mountney J (August 1997). "Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia". <i>Arteriosclerosis, Thrombosis, and Vascular Biology</i>. <b>17</b> (8): 1527–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1161%2F01.ATV.17.8.1527  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2F01.ATV.17.8.1527'" tppabs="https://doi.org/10.1161%2F01.ATV.17.8.1527" class="external text external">10.1161/01.ATV.17.8.1527</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9301631  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9301631'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9301631" class="external text external">9301631</a>.</cite></span></li><li id="cite_note-AMH_2006-14"> <span id="mw-reference-text-cite_note-AMH_2006-14" class="mw-reference-text"><cite id="CITEREFRossi_S2006" class="citation book cs1">Rossi S, ed. (2006). <i>Australian medicines handbook 2006</i>. Adelaide, S. Aust: Australian Medicines Handbook Pty Ltd. ISBN<span>&nbsp;</span><bdi>978-0-9757919-2-9</bdi>.</cite></span></li><li id="cite_note-Lipitor_label-15"> <span id="mw-reference-text-cite_note-Lipitor_label-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6e131fe-e7df-4876-83f7-9156fc4e8228  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6e131fe-e7df-4876-83f7-9156fc4e8228'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6e131fe-e7df-4876-83f7-9156fc4e8228" class="external text external">"Lipitor- atorvastatin calcium tablet, film coated"</a>. <i>DailyMed</i><span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2020</span>.</cite></span></li><li id="cite_note-pmid12686036-16"> <span id="mw-reference-text-cite_note-pmid12686036-16" class="mw-reference-text"><cite id="CITEREFSeverDahlöfPoulterWedel2003" class="citation journal cs1">Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M,  et al. (April 2003). "Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial". <i>Lancet</i>. <b>361</b> (9364): 1149–58. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2803%2912948-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2803%2912948-0'" tppabs="https://doi.org/10.1016%2FS0140-6736%2803%2912948-0" class="external text external">10.1016/S0140-6736(03)12948-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12686036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12686036'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12686036" class="external text external">12686036</a>.</cite></span></li><li id="cite_note-pmid12829554-17"> <span id="mw-reference-text-cite_note-pmid12829554-17" class="mw-reference-text"><cite id="CITEREFLawWaldRudnicka2003" class="citation journal cs1">Law MR, Wald NJ, Rudnicka AR (June 2003). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC162260  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC162260'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC162260" class="external text external">"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis"</a>. <i>BMJ</i>. <b>326</b> (7404): 1423–0. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.326.7404.1423  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.326.7404.1423'" tppabs="https://doi.org/10.1136%2Fbmj.326.7404.1423" class="external text external">10.1136/bmj.326.7404.1423</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC162260  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC162260'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC162260" class="external text external">162260</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12829554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12829554'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12829554" class="external text external">12829554</a>.</cite></span></li><li id="cite_note-Wilson_2008-18"> <span id="mw-reference-text-cite_note-Wilson_2008-18" class="mw-reference-text"><cite id="CITEREFWilsonD'AgostinoLevyBelanger1998" class="citation journal cs1">Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (May 1998). <a href="javascript:if(confirm('https://doi.org/10.1161/01.CIR.97.18.1837  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161/01.CIR.97.18.1837'" tppabs="https://doi.org/10.1161/01.CIR.97.18.1837" class="external text external">"Prediction of coronary heart disease using risk factor categories"</a>. <i>Circulation</i>. <b>97</b> (18): 1837–47. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2F01.CIR.97.18.1837  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2F01.CIR.97.18.1837'" tppabs="https://doi.org/10.1161%2F01.CIR.97.18.1837" class="external text external">10.1161/01.CIR.97.18.1837</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9603539  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9603539'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9603539" class="external text external">9603539</a>.</cite></span></li><li id="cite_note-pmid9514454-19"> <span id="mw-reference-text-cite_note-pmid9514454-19" class="mw-reference-text"><cite id="CITEREFJonesKafonekLauroraHunninghake1998" class="citation journal cs1">Jones P, Kafonek S, Laurora I, Hunninghake D (March 1998). "Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)". <i>The American Journal of Cardiology</i>. <b>81</b> (5): 582–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0002-9149%2897%2900965-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0002-9149%2897%2900965-X'" tppabs="https://doi.org/10.1016%2FS0002-9149%2897%2900965-X" class="external text external">10.1016/S0002-9149(97)00965-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9514454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9514454'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9514454" class="external text external">9514454</a>.</cite></span></li><li id="cite_note-pmid15325833-20"> <span id="mw-reference-text-cite_note-pmid15325833-20" class="mw-reference-text"><cite id="CITEREFColhounBetteridgeDurringtonHitman2004" class="citation journal cs1">Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ,  et al. (2004). "Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial". <i>Lancet</i>. <b>364</b> (9435): 685–96. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2804%2916895-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2804%2916895-5'" tppabs="https://doi.org/10.1016%2FS0140-6736%2804%2916895-5" class="external text external">10.1016/S0140-6736(04)16895-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15325833  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15325833'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15325833" class="external text external">15325833</a>.</cite></span></li><li id="cite_note-pmid17065671-21"> <span id="mw-reference-text-cite_note-pmid17065671-21" class="mw-reference-text"><cite id="CITEREFNeilDeMiccoLuoBetteridge2006" class="citation journal cs1">Neil HA, DeMicco DA, Luo D, Betteridge DJ, Colhoun HM, Durrington PN,  et al. (November 2006). <a href="javascript:if(confirm('https://doi.org/10.2337/dc06-0872  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2337/dc06-0872'" tppabs="https://doi.org/10.2337/dc06-0872" class="external text external">"Analysis of efficacy and safety in patients aged 65–75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)"</a>. <i>Diabetes Care</i>. <b>29</b> (11): 2378–84. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.2337%2Fdc06-0872  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2337%2Fdc06-0872'" tppabs="https://doi.org/10.2337%2Fdc06-0872" class="external text external">10.2337/dc06-0872</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17065671  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17065671'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17065671" class="external text external">17065671</a>.</cite></span></li><li id="cite_note-pmid11225965-22"> <span id="mw-reference-text-cite_note-pmid11225965-22" class="mw-reference-text"><cite id="CITEREFGentileTurcoGuarinoSasso2000" class="citation journal cs1">Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P,  et al. (December 2000). "Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia". <i>Diabetes, Obesity &amp; Metabolism</i>. <b>2</b> (6): 355–62. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1463-1326.2000.00106.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1463-1326.2000.00106.x'" tppabs="https://doi.org/10.1046%2Fj.1463-1326.2000.00106.x" class="external text external">10.1046/j.1463-1326.2000.00106.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11225965  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11225965'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11225965" class="external text external">11225965</a>.</cite></span></li><li id="cite_note-Rosa_501–15-23"> <span id="mw-reference-text-cite_note-Rosa_501–15-23" class="mw-reference-text"><cite id="CITEREFRosaCarboneParodiMassimelli2014" class="citation journal cs1">Rosa GM, Carbone F, Parodi A, Massimelli EA, Brunelli C, Mach F,  et al. (May 2014). "Update on the efficacy of statin treatment in acute coronary syndromes". <i>European Journal of Clinical Investigation</i>. <b>44</b> (5): 501–15. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Feci.12255  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Feci.12255'" tppabs="https://doi.org/10.1111%2Feci.12255" class="external text external">10.1111/eci.12255</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24601937  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24601937'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24601937" class="external text external">24601937</a>.</cite></span></li><li id="cite_note-Furie_1994–5-24"> <span id="mw-reference-text-cite_note-Furie_1994–5-24" class="mw-reference-text"><cite id="CITEREFFurie2012" class="citation journal cs1">Furie KL (July 2012). <a href="javascript:if(confirm('https://doi.org/10.1161/STROKEAHA.111.633339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161/STROKEAHA.111.633339'" tppabs="https://doi.org/10.1161/STROKEAHA.111.633339" class="external text external">"High-dose statins should only be used in atherosclerotic strokes"</a>. <i>Stroke</i>. <b>43</b> (7): 1994–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2FSTROKEAHA.111.633339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2FSTROKEAHA.111.633339'" tppabs="https://doi.org/10.1161%2FSTROKEAHA.111.633339" class="external text external">10.1161/STROKEAHA.111.633339</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22581818  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22581818'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22581818" class="external text external">22581818</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFSuZhangLvWang2016" class="citation journal cs1">Su X, Zhang L, Lv J, Wang J, Hou W, Xie X, Zhang H (June 2016). <a href="javascript:if(confirm('https://doi.org/10.1053/j.ajkd.2016.01.016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1053/j.ajkd.2016.01.016'" tppabs="https://doi.org/10.1053/j.ajkd.2016.01.016" class="external text external">"Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis"</a>. <i>American Journal of Kidney Diseases</i>. <b>67</b> (6): 881–92. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1053%2Fj.ajkd.2016.01.016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1053%2Fj.ajkd.2016.01.016'" tppabs="https://doi.org/10.1053%2Fj.ajkd.2016.01.016" class="external text external">10.1053/j.ajkd.2016.01.016</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26905361  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26905361'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26905361" class="external text external">26905361</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFXiongNieCaoZou2017" class="citation journal cs1">Xiong B, Nie D, Cao Y, Zou Y, Yao Y, Qian J,  et al. (November 2017). "Preoperative Statin Treatment for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomised Controlled Trials". <i>Heart, Lung &amp; Circulation</i>. <b>26</b> (11): 1200–1207. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.hlc.2016.11.024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.hlc.2016.11.024'" tppabs="https://doi.org/10.1016%2Fj.hlc.2016.11.024" class="external text external">10.1016/j.hlc.2016.11.024</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28242291  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28242291'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28242291" class="external text external">28242291</a>.</cite></span></li><li id="cite_note-Zhou_2018-27"> <span id="mw-reference-text-cite_note-Zhou_2018-27" class="mw-reference-text"><cite id="CITEREFZhouDaiXuWang2019" class="citation journal cs1">Zhou X, Dai J, Xu X, Wang Z, Xu H, Chen J,  et al. (April 2019). "Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis". <i>Angiology</i>. <b>70</b> (4): 305–316. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0003319718801246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0003319718801246'" tppabs="https://doi.org/10.1177%2F0003319718801246" class="external text external">10.1177/0003319718801246</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30261736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30261736'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30261736" class="external text external">30261736</a>.</cite></span></li><li id="cite_note-Fan_2016-28"> <span id="mw-reference-text-cite_note-Fan_2016-28" class="mw-reference-text"><cite id="CITEREFMaZhaoWangHan2018" class="citation journal cs1">Ma WQ, Zhao Y, Wang Y, Han XQ, Zhu Y, Liu NF (June 2018). <a href="javascript:if(confirm('http://www.ijcem.com/files/ijcem0015476.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ijcem.com/files/ijcem0015476.pdf'" tppabs="http://www.ijcem.com/files/ijcem0015476.pdf" class="external text external">"Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials"</a> <span class="cs1-format">(PDF)</span>. <i>International Urology and Nephrology</i>. <b>50</b> (6): 1085–1095. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11255-018-1814-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11255-018-1814-0'" tppabs="https://doi.org/10.1007%2Fs11255-018-1814-0" class="external text external">10.1007/s11255-018-1814-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29404930  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29404930'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29404930" class="external text external">29404930</a>.</cite></span></li><li id="cite_note-Cho_2020-29"> <span id="mw-reference-text-cite_note-Cho_2020-29" class="mw-reference-text"><cite id="CITEREFChoLeeSohn2020" class="citation journal cs1">Cho A, Lee YK, Sohn SY (March 2020). <a href="javascript:if(confirm('https://doi.org/10.1097/MD.0000000000019473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097/MD.0000000000019473'" tppabs="https://doi.org/10.1097/MD.0000000000019473" class="external text external">"Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis"</a>. <i>Medicine</i>. <b>99</b> (10): e19473. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1097%2FMD.0000000000019473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FMD.0000000000019473'" tppabs="https://doi.org/10.1097%2FMD.0000000000019473" class="external text external">10.1097/MD.0000000000019473</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/32150109  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/32150109'" tppabs="https://pubmed.ncbi.nlm.nih.gov/32150109" class="external text external">32150109</a>.</cite></span></li><li id="cite_note-Zhang_2018-30"> <span id="mw-reference-text-cite_note-Zhang_2018-30" class="mw-reference-text"><cite id="CITEREFZhangGuoJinBian2018" class="citation journal cs1">Zhang J, Guo Y, Jin Q, Bian L, Lin P (October 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216974'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216974" class="external text external">"Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury"</a>. <i>Drug Design, Development and Therapy</i>. <b>12</b>: 3685–3690. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FDDDT.S178020  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FDDDT.S178020'" tppabs="https://doi.org/10.2147%2FDDDT.S178020" class="external text external">10.2147/DDDT.S178020</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216974'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216974" class="external text external">6216974</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30464400  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30464400'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30464400" class="external text external">30464400</a>.</cite></span></li><li id="cite_note-pmid11368702-31"> <span id="mw-reference-text-cite_note-pmid11368702-31" class="mw-reference-text"><cite id="CITEREFExpert_Panel_on_Detection,_Evaluation,_and_Treatment_of_High_Blood_Cholesterol_in_Adults2001" class="citation journal cs1">Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (May 2001). "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)". <i>JAMA</i>. <b>285</b> (19): 2486–97. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.285.19.2486  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.285.19.2486'" tppabs="https://doi.org/10.1001%2Fjama.285.19.2486" class="external text external">10.1001/jama.285.19.2486</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11368702  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11368702'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11368702" class="external text external">11368702</a>.</cite></span></li><li id="cite_note-pmid15249516-32"> <span id="mw-reference-text-cite_note-pmid15249516-32" class="mw-reference-text"><cite id="CITEREFGrundyCleemanMerzBrewer2004" class="citation journal cs1">Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB,  et al. (July 2004). <a href="javascript:if(confirm('https://doi.org/10.1161/01.CIR.0000133317.49796.0E  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161/01.CIR.0000133317.49796.0E'" tppabs="https://doi.org/10.1161/01.CIR.0000133317.49796.0E" class="external text external">"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines"</a>. <i>Circulation</i>. <b>110</b> (2): 227–39. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2F01.CIR.0000133317.49796.0E  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2F01.CIR.0000133317.49796.0E'" tppabs="https://doi.org/10.1161%2F01.CIR.0000133317.49796.0E" class="external text external">10.1161/01.CIR.0000133317.49796.0E</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15249516  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15249516'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15249516" class="external text external">15249516</a>.</cite></span></li><li id="cite_note-LactMed_Atorvastatin-33"> <span id="mw-reference-text-cite_note-LactMed_Atorvastatin-33" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~r09l0q:1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~r09l0q:1'" tppabs="https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~r09l0q:1" class="external text external">"TOXNET"</a>. <i>toxnet.nlm.nih.gov</i>. U.S. National Library of Medicine<span class="reference-accessdate">. Retrieved <span class="nowrap">29 May</span> 2018</span>.</cite></span></li><li id="cite_note-pmid16765141-34"> <span id="mw-reference-text-cite_note-pmid16765141-34" class="mw-reference-text"><cite id="CITEREFHermannBogsrudMoldenAsberg2006" class="citation journal cs1">Hermann M, Bogsrud MP, Molden E, Asberg A, Mohebi BU, Ose L, Retterstøl K (June 2006). "Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy". <i>Clinical Pharmacology and Therapeutics</i>. <b>79</b> (6): 532–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clpt.2006.02.014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clpt.2006.02.014'" tppabs="https://doi.org/10.1016%2Fj.clpt.2006.02.014" class="external text external">10.1016/j.clpt.2006.02.014</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16765141  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16765141'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16765141" class="external text external">16765141</a>.</cite></span></li><li id="cite_note-pmid12036392-35"> <span id="mw-reference-text-cite_note-pmid12036392-35" class="mw-reference-text"><cite id="CITEREFWilliamsFeely2002" class="citation journal cs1">Williams D, Feely J (2002). "Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors". <i>Clinical Pharmacokinetics</i>. <b>41</b> (5): 343–70. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200241050-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200241050-00003'" tppabs="https://doi.org/10.2165%2F00003088-200241050-00003" class="external text external">10.2165/00003088-200241050-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12036392  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12036392'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12036392" class="external text external">12036392</a>.</cite></span></li><li id="cite_note-FDA_2014_statins-36"> <span id="mw-reference-text-cite_note-FDA_2014_statins-36" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/consumers/consumer-updates/controlling-cholesterol-statins  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/consumers/consumer-updates/controlling-cholesterol-statins'" tppabs="https://www.fda.gov/consumers/consumer-updates/controlling-cholesterol-statins" class="external text external">"FDA Expands Advice on Statin Risks"</a>. U.S. Food and Drug Administration (FDA). 31 January 2014. <a href="javascript:if(confirm('https://web.archive.org/web/20151118155549/https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151118155549/https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm'" tppabs="https://web.archive.org/web/20151118155549/https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm" class="external text external">Archived</a> from the original on 18 November 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">24 November</span> 2015</span>.</cite></span></li><li id="cite_note-webmd_2012_diabetes-37"> <span id="mw-reference-text-cite_note-webmd_2012_diabetes-37" class="mw-reference-text"><cite id="CITEREFSalynn2012" class="citation web cs1">Salynn B (9 January 2012). <a href="javascript:if(confirm('https://www.webmd.com/cholesterol-management/news/20120109/statins-may-raise-diabetes-risk-in-older-women  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.webmd.com/cholesterol-management/news/20120109/statins-may-raise-diabetes-risk-in-older-women'" tppabs="https://www.webmd.com/cholesterol-management/news/20120109/statins-may-raise-diabetes-risk-in-older-women" class="external text external">"Statins May Raise Diabetes Risk in Older Women: Study: Middle-Aged, Older Statin Users Had More Type 2 Diabetes"</a>. WebMD Health News<span class="reference-accessdate">. Retrieved <span class="nowrap">24 November</span> 2015</span>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFShahGoldfine2012" class="citation journal cs1">Shah RV, Goldfine AB (October 2012). <a href="javascript:if(confirm('https://doi.org/10.1161/CIRCULATIONAHA.112.122135  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161/CIRCULATIONAHA.112.122135'" tppabs="https://doi.org/10.1161/CIRCULATIONAHA.112.122135" class="external text external">"Statins and risk of new-onset diabetes mellitus"</a>. <i>Circulation</i>. <b>126</b> (18): e282–4. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2FCIRCULATIONAHA.112.122135  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2FCIRCULATIONAHA.112.122135'" tppabs="https://doi.org/10.1161%2FCIRCULATIONAHA.112.122135" class="external text external">10.1161/CIRCULATIONAHA.112.122135</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23109518  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23109518'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23109518" class="external text external">23109518</a>.</cite></span></li><li id="cite_note-pmid8463436-39"> <span id="mw-reference-text-cite_note-pmid8463436-39" class="mw-reference-text"><cite id="CITEREFGhirlandaOradeiMantoLippa1993" class="citation journal cs1">Ghirlanda G, Oradei A, Manto A, Lippa S, Uccioli L, Caputo S,  et al. (March 1993). "Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study". <i>Journal of Clinical Pharmacology</i>. <b>33</b> (3): 226–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fj.1552-4604.1993.tb03948.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fj.1552-4604.1993.tb03948.x'" tppabs="https://doi.org/10.1002%2Fj.1552-4604.1993.tb03948.x" class="external text external">10.1002/j.1552-4604.1993.tb03948.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8463436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8463436'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8463436" class="external text external">8463436</a>.</cite></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite id="CITEREFMacedoTaylorCasasAdler2014" class="citation journal cs1">Macedo AF, Taylor FC, Casas JP, Adler A, Prieto-Merino D, Ebrahim S (March 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998050  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998050'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998050" class="external text external">"Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis"</a>. <i>BMC Medicine</i>. <b>12</b>: 51. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1741-7015-12-51  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1741-7015-12-51'" tppabs="https://doi.org/10.1186%2F1741-7015-12-51" class="external text external">10.1186/1741-7015-12-51</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998050  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998050'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998050" class="external text external">3998050</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24655568  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24655568'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24655568" class="external text external">24655568</a>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite id="CITEREFKashaniPhillipsFoodyWang2006" class="citation journal cs1">Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM (December 2006). <a href="javascript:if(confirm('https://doi.org/10.1161/CIRCULATIONAHA.106.624890  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161/CIRCULATIONAHA.106.624890'" tppabs="https://doi.org/10.1161/CIRCULATIONAHA.106.624890" class="external text external">"Risks associated with statin therapy: a systematic overview of randomized clinical trials"</a>. <i>Circulation</i>. <b>114</b> (25): 2788–97. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2FCIRCULATIONAHA.106.624890  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2FCIRCULATIONAHA.106.624890'" tppabs="https://doi.org/10.1161%2FCIRCULATIONAHA.106.624890" class="external text external">10.1161/CIRCULATIONAHA.106.624890</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17159064  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17159064'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17159064" class="external text external">17159064</a>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFNewmanPalmerSilbershatzSzarek2003" class="citation journal cs1">Newman CB, Palmer G, Silbershatz H, Szarek M (September 2003). "Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients". <i>American Journal of Cardiology</i>. <b>92</b> (6): 670–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0002-9149%2803%2900820-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0002-9149%2803%2900820-8'" tppabs="https://doi.org/10.1016%2FS0002-9149%2803%2900820-8" class="external text external">10.1016/S0002-9149(03)00820-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12972104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12972104'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12972104" class="external text external">12972104</a>.</cite></span></li><li id="cite_note-Mayo_Clinic_Staff-43"> <span id="mw-reference-text-cite_note-Mayo_Clinic_Staff-43" class="mw-reference-text"><cite id="CITEREFMayo_Clinic_Staff" class="citation web cs1">Mayo Clinic Staff. <a href="javascript:if(confirm('https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statin-side-effects/art-20046013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statin-side-effects/art-20046013'" tppabs="https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statin-side-effects/art-20046013" class="external text external">"Statin Side Effects: Weigh the Risks and Benefits"</a>. The Mayo Clinic<span class="reference-accessdate">. Retrieved <span class="nowrap">19 April</span> 2014</span>.</cite></span></li><li id="cite_note-pmid20507274-44"> <span id="mw-reference-text-cite_note-pmid20507274-44" class="mw-reference-text"><cite id="CITEREFKostapanosLiamisMilionisElisaf2010" class="citation journal cs1">Kostapanos MS, Liamis GL, Milionis HJ, Elisaf MS (September 2010). "Do statins beneficially or adversely affect glucose homeostasis?". <i>Current Vascular Pharmacology</i>. <b>8</b> (5): 612–31. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F157016110792006879  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F157016110792006879'" tppabs="https://doi.org/10.2174%2F157016110792006879" class="external text external">10.2174/157016110792006879</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20507274  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20507274'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20507274" class="external text external">20507274</a>.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite id="CITEREFWolfeKanjiYazdiBarbeau2020" class="citation journal cs1">Wolfe D, Kanji S, Yazdi F, Barbeau P, Rice D, Beck A, Butler C, Esmaeilisaraji L, Skidmore B, Moher D, Hutton B (2020). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164626  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164626'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164626" class="external text external">"Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations"</a>. <i>PLOS ONE</i>. <b>15</b> (4): e0231883. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0231883  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0231883'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0231883" class="external text external">10.1371/journal.pone.0231883</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164626  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164626'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164626" class="external text external">7164626</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/32302358  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/32302358'" tppabs="https://pubmed.ncbi.nlm.nih.gov/32302358" class="external text external">32302358</a>.</cite></span></li><li id="cite_note-pmid18158710-46"> <span id="mw-reference-text-cite_note-pmid18158710-46" class="mw-reference-text"><cite id="CITEREFSteiner2007" class="citation journal cs1">Steiner G (December 2007). "Atherosclerosis in type 2 diabetes: a role for fibrate therapy?". <i>Diabetes &amp; Vascular Disease Research</i>. <b>4</b> (4): 368–74. doi:<a href="javascript:if(confirm('https://doi.org/10.3132%2Fdvdr.2007.067  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3132%2Fdvdr.2007.067'" tppabs="https://doi.org/10.3132%2Fdvdr.2007.067" class="external text external">10.3132/dvdr.2007.067</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18158710  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18158710'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18158710" class="external text external">18158710</a>.</cite></span></li><li id="cite_note-Graham2004-47"> <span id="mw-reference-text-cite_note-Graham2004-47" class="mw-reference-text"><cite id="CITEREFGrahamStaffaShatinAndrade2004" class="citation journal cs1">Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L,  et al. (December 2004). <a href="javascript:if(confirm('https://doi.org/10.1001/jama.292.21.2585  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/jama.292.21.2585'" tppabs="https://doi.org/10.1001/jama.292.21.2585" class="external text external">"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs"</a>. <i>JAMA</i>. <b>292</b> (21): 2585–90. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.292.21.2585  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.292.21.2585'" tppabs="https://doi.org/10.1001%2Fjama.292.21.2585" class="external text external">10.1001/jama.292.21.2585</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15572716  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15572716'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15572716" class="external text external">15572716</a>.</cite></span></li><li id="cite_note-pmid11061579-48"> <span id="mw-reference-text-cite_note-pmid11061579-48" class="mw-reference-text"><cite id="CITEREFMazzuLasseterShamblenAgarwal2000" class="citation journal cs1">Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P (October 2000). "Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin". <i>Clinical Pharmacology and Therapeutics</i>. <b>68</b> (4): 391–400. doi:<a href="javascript:if(confirm('https://doi.org/10.1067%2Fmcp.2000.110537  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1067%2Fmcp.2000.110537'" tppabs="https://doi.org/10.1067%2Fmcp.2000.110537" class="external text external">10.1067/mcp.2000.110537</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11061579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11061579'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11061579" class="external text external">11061579</a>.</cite></span></li><li id="cite_note-pmid17178259-49"> <span id="mw-reference-text-cite_note-pmid17178259-49" class="mw-reference-text"><cite id="CITEREFNeuvonenNiemiBackman2006" class="citation journal cs1">Neuvonen PJ, Niemi M, Backman JT (December 2006). "Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance". <i>Clinical Pharmacology and Therapeutics</i>. <b>80</b> (6): 565–81. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clpt.2006.09.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clpt.2006.09.003'" tppabs="https://doi.org/10.1016%2Fj.clpt.2006.09.003" class="external text external">10.1016/j.clpt.2006.09.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17178259  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17178259'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17178259" class="external text external">17178259</a>.</cite></span></li><li id="cite_note-pmid16084850-50"> <span id="mw-reference-text-cite_note-pmid16084850-50" class="mw-reference-text"><cite id="CITEREFBackmanLuurilaNeuvonenNeuvonen2005" class="citation journal cs1">Backman JT, Luurila H, Neuvonen M, Neuvonen PJ (August 2005). "Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites". <i>Clinical Pharmacology and Therapeutics</i>. <b>78</b> (2): 154–67. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clpt.2005.04.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clpt.2005.04.007'" tppabs="https://doi.org/10.1016%2Fj.clpt.2005.04.007" class="external text external">10.1016/j.clpt.2005.04.007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16084850  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16084850'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16084850" class="external text external">16084850</a>.</cite></span></li><li id="cite_note-pmid15901588-51"> <span id="mw-reference-text-cite_note-pmid15901588-51" class="mw-reference-text"><cite id="CITEREFMcKenney2005" class="citation journal cs1">McKenney JM (May 2005). "Efficacy and safety of rosuvastatin in treatment of dyslipidemia". <i>American Journal of Health-System Pharmacy</i>. <b>62</b> (10): 1033–47. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fajhp%2F62.10.1033  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fajhp%2F62.10.1033'" tppabs="https://doi.org/10.1093%2Fajhp%2F62.10.1033" class="external text external">10.1093/ajhp/62.10.1033</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15901588  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15901588'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15901588" class="external text external">15901588</a>.</cite></span></li><li id="cite_note-Wiggins_et_al-52"> <span id="mw-reference-text-cite_note-Wiggins_et_al-52" class="mw-reference-text"><cite id="CITEREFWigginsSaseenPageReed2016" class="citation journal cs1">Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB,  et al. (November 2016). "Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association". <i>Circulation</i>. <b>134</b> (21): e468–e495. doi:<a href="javascript:if(confirm('https://doi.org/10.1161%2FCIR.0000000000000456  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2FCIR.0000000000000456'" tppabs="https://doi.org/10.1161%2FCIR.0000000000000456" class="external text external">10.1161/CIR.0000000000000456</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27754879  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27754879'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27754879" class="external text external">27754879</a>.</cite></span></li><li id="cite_note-pmid18754003-53"> <span id="mw-reference-text-cite_note-pmid18754003-53" class="mw-reference-text"><cite id="CITEREFSchwartz2009" class="citation journal cs1">Schwartz JB (February 2009). "Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence". <i>Clinical Pharmacology and Therapeutics</i>. <b>85</b> (2): 198–203. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fclpt.2008.165  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fclpt.2008.165'" tppabs="https://doi.org/10.1038%2Fclpt.2008.165" class="external text external">10.1038/clpt.2008.165</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18754003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18754003'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18754003" class="external text external">18754003</a>.</cite></span></li><li id="cite_note-Kane2000-54"> <span id="mw-reference-text-cite_note-Kane2000-54" class="mw-reference-text"><cite id="CITEREFKaneLipsky2000" class="citation journal cs1">Kane GC, Lipsky JJ (September 2000). <a href="javascript:if(confirm('https://doi.org/10.4065/75.9.933  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065/75.9.933'" tppabs="https://doi.org/10.4065/75.9.933" class="external text external">"Drug-grapefruit juice interactions"</a>. <i>Mayo Clinic Proceedings</i>. <b>75</b> (9): 933–42. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4065%2F75.9.933  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4065%2F75.9.933'" tppabs="https://doi.org/10.4065%2F75.9.933" class="external text external">10.4065/75.9.933</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10994829  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10994829'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10994829" class="external text external">10994829</a>.</cite></span></li><li id="cite_note-:1-55"> <span id="mw-reference-text-cite_note-:1-55" class="mw-reference-text"><cite id="CITEREFAndoTsuruokaYanagiharaSugimoto2005" class="citation journal cs1">Ando H, Tsuruoka S, Yanagihara H, Sugimoto K, Miyata M, Yamazoe Y,  et al. (November 2005). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884940  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884940'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884940" class="external text external">"Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>60</b> (5): 494–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.2005.02462.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.2005.02462.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.2005.02462.x" class="external text external">10.1111/j.1365-2125.2005.02462.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884940  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884940'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884940" class="external text external">1884940</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16236039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16236039'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16236039" class="external text external">16236039</a>.</cite></span></li><li id="cite_note-:2-56"> <span id="mw-reference-text-cite_note-:2-56" class="mw-reference-text"><cite id="CITEREFReddyEllingtonZhuZdrojewski2011" class="citation journal cs1">Reddy P, Ellington D, Zhu Y, Zdrojewski I, Parent SJ, Harmatz JS,  et al. (September 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175512'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175512" class="external text external">"Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>72</b> (3): 434–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.2011.03996.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.2011.03996.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.2011.03996.x" class="external text external">10.1111/j.1365-2125.2011.03996.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175512'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175512" class="external text external">3175512</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21501216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21501216'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21501216" class="external text external">21501216</a>.</cite></span></li><li id="cite_note-:3-57"> <span id="mw-reference-text-cite_note-:3-57" class="mw-reference-text"><cite id="CITEREFLiljaKivistöNeuvonen1999" class="citation journal cs1">Lilja JJ, Kivistö KT, Neuvonen PJ (August 1999). "Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin". <i>Clinical Pharmacology and Therapeutics</i>. <b>66</b> (2): 118–27. doi:<a href="javascript:if(confirm('https://doi.org/10.1053%2Fcp.1999.v66.100453001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1053%2Fcp.1999.v66.100453001'" tppabs="https://doi.org/10.1053%2Fcp.1999.v66.100453001" class="external text external">10.1053/cp.1999.v66.100453001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10460065  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10460065'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10460065" class="external text external">10460065</a>.</cite></span></li><li id="cite_note-58"> <span id="mw-reference-text-cite_note-58" class="mw-reference-text"><cite id="CITEREFMcLachlanRamzan2006" class="citation journal cs1">McLachlan, Andrew; Ramzan, Iqbal (1 April 2006). <a href="javascript:if(confirm('https://www.nps.org.au/australian-prescriber/magazine/29/2/40/2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nps.org.au/australian-prescriber/magazine/29/2/40/2'" tppabs="https://www.nps.org.au/australian-prescriber/magazine/29/2/40/2" class="external text external">"Meals and medicines"</a>. <i>Australian Prescriber</i>. <b>29</b> (2): 40–42. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.18773%2Faustprescr.2006.026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.18773%2Faustprescr.2006.026'" tppabs="https://doi.org/10.18773%2Faustprescr.2006.026" class="external text external">10.18773/austprescr.2006.026</a></span>.</cite></span></li><li id="cite_note-:0-59"> <span id="mw-reference-text-cite_note-:0-59" class="mw-reference-text"><cite id="CITEREFLiberaleCarboneMontecuccoSahebkar2020" class="citation journal cs1">Liberale L, Carbone F, Montecucco F, Sahebkar A (May 2020). "Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms". <i>International Journal of Biochemistry &amp; Cell Biology</i>. <b>122</b>: 105735. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.biocel.2020.105735  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.biocel.2020.105735'" tppabs="https://doi.org/10.1016%2Fj.biocel.2020.105735" class="external text external">10.1016/j.biocel.2020.105735</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/32126319  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/32126319'" tppabs="https://pubmed.ncbi.nlm.nih.gov/32126319" class="external text external">32126319</a>.</cite></span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite id="CITEREFAdamsTsangWright2015" class="citation journal cs1">Adams SP, Tsang M, Wright JM (March 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464917  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464917'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464917" class="external text external">"Atorvastatin for lowering lipids"</a>. <i>Cochrane Database of Systematic Reviews</i> (3): CD008226. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.cd008226.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.cd008226.pub3'" tppabs="https://doi.org/10.1002%2F14651858.cd008226.pub3" class="external text external">10.1002/14651858.cd008226.pub3</a></span>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464917  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464917'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464917" class="external text external">6464917</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25760954  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25760954'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25760954" class="external text external">25760954</a>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFCanestaroAustinThummel2014" class="citation journal cs1">Canestaro WJ, Austin MA, Thummel KE (November 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676271  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676271'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676271" class="external text external">"Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review"</a>. <i>Genet Med</i>. <b>16</b> (11): 810–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fgim.2014.41  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fgim.2014.41'" tppabs="https://doi.org/10.1038%2Fgim.2014.41" class="external text external">10.1038/gim.2014.41</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676271  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676271'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676271" class="external text external">4676271</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24810685  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24810685'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24810685" class="external text external">24810685</a>.</cite></span></li><li id="cite_note-pmid22368281-62"> <span id="mw-reference-text-cite_note-pmid22368281-62" class="mw-reference-text"><cite id="CITEREFDeshmukhColhounJohnsonMcKeigue2012" class="citation journal cs1">Deshmukh HA, Colhoun HM, Johnson T, McKeigue PM, Betteridge DJ, Durrington PN,  et al. (May 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329377  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329377'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329377" class="external text external">"Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)"</a>. <i>Journal of Lipid Research</i>. <b>53</b> (5): 1000–11. doi:<a href="javascript:if(confirm('https://doi.org/10.1194%2Fjlr.P021113  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1194%2Fjlr.P021113'" tppabs="https://doi.org/10.1194%2Fjlr.P021113" class="external text external">10.1194/jlr.P021113</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329377  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329377'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329377" class="external text external">3329377</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22368281  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22368281'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22368281" class="external text external">22368281</a>.</cite></span></li><li id="cite_note-Thompson_JF-63"> <span id="mw-reference-text-cite_note-Thompson_JF-63" class="mw-reference-text"><cite id="CITEREFThompsonManJohnsonWood2005" class="citation journal cs1">Thompson JF, Man M, Johnson KJ, Wood LS, Lira ME, Lloyd DB,  et al. (2005). <a href="javascript:if(confirm('https://doi.org/10.1038/sj.tpj.6500328  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038/sj.tpj.6500328'" tppabs="https://doi.org/10.1038/sj.tpj.6500328" class="external text external">"An association study of 43 SNPs in 16 candidate genes with atorvastatin response"</a>. <i>Pharmacogenomics Journal</i>. <b>5</b> (6): 352–8. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.tpj.6500328  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.tpj.6500328'" tppabs="https://doi.org/10.1038%2Fsj.tpj.6500328" class="external text external">10.1038/sj.tpj.6500328</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16103896  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16103896'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16103896" class="external text external">16103896</a>.</cite></span></li><li id="cite_note-Fortune_2003-64"> <span id="mw-reference-text-cite_note-Fortune_2003-64" class="mw-reference-text"><cite id="CITEREFSimons2003" class="citation web cs1">Simons J (20 January 2003). <a href="javascript:if(confirm('https://archive.fortune.com/magazines/fortune/fortune_archive/2003/01/20/335643/index.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.fortune.com/magazines/fortune/fortune_archive/2003/01/20/335643/index.htm'" tppabs="https://archive.fortune.com/magazines/fortune/fortune_archive/2003/01/20/335643/index.htm" class="external text external">"The $10 Billion Pill Hold the fries, please. Lipitor, the cholesterol-lowering medication, has become the bestselling pharmaceutical in history. Here's how Pfizer did it"</a>. <i>Fortune</i>.</cite></span></li><li id="cite_note-FT_nov_2009-65"> <span id="mw-reference-text-cite_note-FT_nov_2009-65" class="mw-reference-text"><cite id="CITEREFAndrew2009" class="citation web cs1">Andrew J (28 November 2009). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.ft.com/content/d0f7af5c-d7e6-11de-b578-00144feabdc0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ft.com/content/d0f7af5c-d7e6-11de-b578-00144feabdc0'" tppabs="https://www.ft.com/content/d0f7af5c-d7e6-11de-b578-00144feabdc0" class="external text external">"The fall of the world's best-selling drug"</a></span>. <i>Financial Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">24 November</span> 2015</span>.</cite></span></li><li id="cite_note-Roth_2002-66"> <span id="mw-reference-text-cite_note-Roth_2002-66" class="mw-reference-text"><cite id="CITEREFRoth2002" class="citation book cs1">Roth BD (2002). <i>The discovery and development of atorvastatin, a potent novel hypolipidemic agent</i>. Progress in Medicinal Chemistry. <b>40</b>. pp.<span>&nbsp;</span>1–22. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0079-6468%2808%2970080-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0079-6468%2808%2970080-8'" tppabs="https://doi.org/10.1016%2FS0079-6468%2808%2970080-8" class="external text external">10.1016/S0079-6468(08)70080-8</a>. ISBN<span>&nbsp;</span><bdi>978-0-444-51054-9</bdi>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12516521  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12516521'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12516521" class="external text external">12516521</a>.</cite></span></li><li id="cite_note-US4681893-67"> <span id="mw-reference-text-cite_note-US4681893-67" class="mw-reference-text"><span class="citation patent" id="CITEREFRoth_Bruce_D.1987"><a href="javascript:if(confirm('https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=US4681893  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=US4681893'" tppabs="https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=US4681893" class="external text external">US<span> </span>patent 4681893</a>,<span> </span>Roth Bruce D.,<span> </span>"Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis",<span> </span>issued 21 July 1987</span></span></li><li id="cite_note-History_Parke-Davis-68"> <span id="mw-reference-text-cite_note-History_Parke-Davis-68" class="mw-reference-text"><cite id="CITEREFHoefle2000" class="citation journal cs1">Hoefle ML (2000). <a href="javascript:if(confirm('https://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/v25-1/v25-1%20p28-34.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/v25-1/v25-1%20p28-34.pdf'" tppabs="https://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/v25-1/v25-1%20p28-34.pdf" class="external text external">"The Early History of Parke-Davis and Company"</a> <span class="cs1-format">(PDF)</span>. <i>Bull. Hist. Chem</i>. <b>25</b> (1): 28–34.</cite></span></li><li id="cite_note-NYT_2000-69"> <span id="mw-reference-text-cite_note-NYT_2000-69" class="mw-reference-text"><cite id="CITEREFPetersen2000" class="citation news cs1">Petersen M (8 February 2000). <a href="javascript:if(confirm('https://www.nytimes.com/2000/02/08/business/pfizer-gets-its-deal-to-buy-warner-lambert-for-90.2-billion.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2000/02/08/business/pfizer-gets-its-deal-to-buy-warner-lambert-for-90.2-billion.html'" tppabs="https://www.nytimes.com/2000/02/08/business/pfizer-gets-its-deal-to-buy-warner-lambert-for-90.2-billion.html" class="external text external">"Pfizer Gets Its Deal to Buy Warner-Lambert for $90.2 Billion"</a>. <i>The New York Times</i>.</cite></span></li><li id="cite_note-Lancet_1994_scandinavia-70"> <span id="mw-reference-text-cite_note-Lancet_1994_scandinavia-70" class="mw-reference-text"><cite id="CITEREFScandinavian_Simvastatin_Survival_Study_Group1994" class="citation journal cs1">Scandinavian Simvastatin Survival Study Group (November 1994). "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)". <i>Lancet</i>. <b>344</b> (8934): 1383–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0140-6736%2894%2990566-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0140-6736%2894%2990566-5'" tppabs="https://doi.org/10.1016%2Fs0140-6736%2894%2990566-5" class="external text external">10.1016/s0140-6736(94)90566-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7968073  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7968073'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7968073" class="external text external">7968073</a>.</cite></span></li><li id="cite_note-WSJ_blockbuster_2000-71"> <span id="mw-reference-text-cite_note-WSJ_blockbuster_2000-71" class="mw-reference-text"><cite id="CITEREFWinslow2000" class="citation news cs1">Winslow R (24 January 2000). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.wsj.com/articles/SB948677773420632448  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/SB948677773420632448'" tppabs="https://www.wsj.com/articles/SB948677773420632448" class="external text external">"The Birth of a Blockbuster: Lipitor's Route out of the Lab"</a></span>. <i>The Wall Street Journal</i><span class="reference-accessdate">. Retrieved <span class="nowrap">26 October</span> 2011</span>.</cite></span></li><li id="cite_note-FDA_Lipitor-72"> <span id="mw-reference-text-cite_note-FDA_Lipitor-72" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020702_s000.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020702_s000.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020702_s000.pdf" class="external text external">"Approval Letter"</a> <span class="cs1-format">(PDF)</span>. U.S. Food and Drug Administration (FDA).</cite></span></li><li id="cite_note-Crain_2011-73"> <span id="mw-reference-text-cite_note-Crain_2011-73" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.crainsnewyork.com/article/20111228/HEALTH_CARE/111229902/lipitor-becomes-world-s-top-selling-drug  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.crainsnewyork.com/article/20111228/HEALTH_CARE/111229902/lipitor-becomes-world-s-top-selling-drug'" tppabs="https://www.crainsnewyork.com/article/20111228/HEALTH_CARE/111229902/lipitor-becomes-world-s-top-selling-drug" class="external text external">"Lipitor becomes world's top-selling drug"</a>. Crain's New York Business via Associated Press. 28 December 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">24 November</span> 2011</span>.</cite></span></li><li id="cite_note-CNN_Wire_Staff-74"> <span id="mw-reference-text-cite_note-CNN_Wire_Staff-74" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://edition.cnn.com/2011/11/30/health/lipitor-generic/index.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://edition.cnn.com/2011/11/30/health/lipitor-generic/index.html'" tppabs="https://edition.cnn.com/2011/11/30/health/lipitor-generic/index.html" class="external text external">"Lipitor loses patent, goes generic"</a>. CNN. 30 November 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">18 November</span> 2012</span>.</cite></span></li><li id="cite_note-75"> <span id="mw-reference-text-cite_note-75" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2018-12-19/g7bs-ahj4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2018-12-19/g7bs-ahj4'" tppabs="https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2018-12-19/g7bs-ahj4" class="external text external">"NADAC as of 2018-12-19"</a>. <i>Centers for Medicare and Medicaid Services</i><span class="reference-accessdate">. Retrieved <span class="nowrap">22 December</span> 2018</span>.</cite></span></li><li id="cite_note-BNF76-76"> <span id="mw-reference-text-cite_note-BNF76-76" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 76</i> (76 ed.). Pharmaceutical Press. 2018. pp.<span>&nbsp;</span>200–201. ISBN<span>&nbsp;</span><bdi>9780857113382</bdi>.</cite></span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.cigna.com/assets/docs/about-cigna/no-cost-share-preventive-medications.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cigna.com/assets/docs/about-cigna/no-cost-share-preventive-medications.pdf'" tppabs="https://www.cigna.com/assets/docs/about-cigna/no-cost-share-preventive-medications.pdf" class="external text external">"PPACA no cost-share preventive medications"</a> <span class="cs1-format">(PDF)</span>. Cigna<span class="reference-accessdate">. Retrieved <span class="nowrap">30 March</span> 2020</span>.</cite></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('https://www.aafp.org/afp/2017/0115/od1.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.aafp.org/afp/2017/0115/od1.html'" tppabs="https://www.aafp.org/afp/2017/0115/od1.html" class="external text external">"Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement"</a>. <i>American Family Physician</i>. <b>95</b> (2). 15 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">31 March</span> 2020</span>.</cite></span></li><li id="cite_note-79"> <span id="mw-reference-text-cite_note-79" class="mw-reference-text"><cite id="CITEREFRothBlankleyChucholowskiFerguson1991" class="citation journal cs1">Roth BD, Blankley CJ, Chucholowski AW, Ferguson E, Hoefle ML, Ortwine DF, Newton RS, Sekerke CS, Sliskovic DR, Wilson M (1991). "Inhibitors of Cholesterol Biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one Inhibitors of HMG-CoA Reductase. 2. Effects of Introducing Substituents at Positions Three and Four of the Pyrrole Nucleus". <i>J. Med. Chem.</i> <b>34</b> (1): 357–366. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjm00105a056  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjm00105a056'" tppabs="https://doi.org/10.1021%2Fjm00105a056" class="external text external">10.1021/jm00105a056</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1992137  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1992137'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1992137" class="external text external">1992137</a>.</cite></span></li><li id="cite_note-80"> <span id="mw-reference-text-cite_note-80" class="mw-reference-text"><cite id="CITEREFJie_Jack_LiDouglas_S._JohnsonDrago_R._SliskovicBruce_D._Roth2004" class="citation book cs1">Jie Jack Li; Douglas S. Johnson; Drago R. Sliskovic; Bruce D. Roth (2004). "Chapter 9. Atorvastatin Calcium (Lipitor)". <i>Contemporary Drug Synthesis</i>. John Wiley &amp; Sons, Inc. pp.<span>&nbsp;</span>113–125. ISBN<span>&nbsp;</span><bdi>978-0-471-21480-9</bdi>.</cite></span></li><li id="cite_note-MPR-81"> <span id="mw-reference-text-cite_note-MPR-81" class="mw-reference-text"><cite id="CITEREFMedical_Product_Reviews" class="citation web cs1">Medical Product Reviews. <a href="javascript:if(confirm('http://www.medicalproductreviews.com/atorvastatin-calcium-lipitor.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medicalproductreviews.com/atorvastatin-calcium-lipitor.html'" tppabs="http://www.medicalproductreviews.com/atorvastatin-calcium-lipitor.html" class="external text external">"Atorvastatin Calcium (Lipitor Tablets) – Uses, Dosage and Side Effects"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">3 May</span> 2012</span>.</cite></span></li><li id="cite_note-NewsMed-82"> <span id="mw-reference-text-cite_note-NewsMed-82" class="mw-reference-text"><cite id="CITEREFNews_Medical2010" class="citation web cs1">News Medical (March 2010). <a href="javascript:if(confirm('http://www.news-medical.net/health/Lipitor-What-is-Lipitor.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.news-medical.net/health/Lipitor-What-is-Lipitor.aspx'" tppabs="http://www.news-medical.net/health/Lipitor-What-is-Lipitor.aspx" class="external text external">"Lipitor – What is Lipitor?"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">3 May</span> 2012</span>.</cite></span></li><li id="cite_note-83"> <span id="mw-reference-text-cite_note-83" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.pm360online.com/pfizers-180-day-war-for-lipitor/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pm360online.com/pfizers-180-day-war-for-lipitor/'" tppabs="https://www.pm360online.com/pfizers-180-day-war-for-lipitor/" class="external text external">"Pfizer's 180-Day War for Lipitor"</a>. <i>PM360</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 April</span> 2020</span>.</cite></span></li><li id="cite_note-84"> <span id="mw-reference-text-cite_note-84" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120920054426/http://www.nelm.nhs.uk/en/NeLM-Area/News/2012---May/30/June-Drug-Tariff-Reduced-prices-for-atorvastatin/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120920054426/http://www.nelm.nhs.uk/en/NeLM-Area/News/2012---May/30/June-Drug-Tariff-Reduced-prices-for-atorvastatin/'" tppabs="https://web.archive.org/web/20120920054426/http://www.nelm.nhs.uk/en/NeLM-Area/News/2012---May/30/June-Drug-Tariff-Reduced-prices-for-atorvastatin/" class="external text external">"Price to UK for 28 tablets from £3.25 (10mg) to £10.00 (80mg)"</a>. National Health Service. June 2012. Archived from <a href="javascript:if(confirm('http://www.nelm.nhs.uk/en/NeLM-Area/News/2012---May/30/June-Drug-Tariff-Reduced-prices-for-atorvastatin/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nelm.nhs.uk/en/NeLM-Area/News/2012---May/30/June-Drug-Tariff-Reduced-prices-for-atorvastatin/'" tppabs="http://www.nelm.nhs.uk/en/NeLM-Area/News/2012---May/30/June-Drug-Tariff-Reduced-prices-for-atorvastatin/" class="external text external">the original</a> on 20 September 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">31 July</span> 2012</span>.</cite></span></li><li id="cite_note-Drugs.com_2020-85"> <span id="mw-reference-text-cite_note-Drugs.com_2020-85" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/atorvastatin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/atorvastatin.html'" tppabs="https://www.drugs.com/international/atorvastatin.html" class="external text external">"Atorvastatin international"</a>. <i>Drugs.com</i>. 4 May 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">10 May</span> 2020</span>.</cite></span></li><li id="cite_note-86"> <span id="mw-reference-text-cite_note-86" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/referrals/lipitor  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/referrals/lipitor'" tppabs="https://www.ema.europa.eu/en/medicines/human/referrals/lipitor" class="external text external">"Lipitor referral"</a>. <i>European Medicines Agency (EMA)</i>. 17 September 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">10 May</span> 2020</span>.</cite></span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite id="CITEREFRapley2012" class="citation news cs1">Rapley L (31 May 2012). <a href="javascript:if(confirm('https://archive.today/20140717211539/http://www.pharmacytoday.co.nz/news/2012/may-2012/31/atorvastatin-sole-funding-announced.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.today/20140717211539/http://www.pharmacytoday.co.nz/news/2012/may-2012/31/atorvastatin-sole-funding-announced.aspx'" tppabs="https://archive.today/20140717211539/http://www.pharmacytoday.co.nz/news/2012/may-2012/31/atorvastatin-sole-funding-announced.aspx" class="external text external">"Atorvastatin sole funding announced"</a>. PharmacyToday.co.nz. Archived from <a href="javascript:if(confirm('http://www.pharmacytoday.co.nz/news/2012/may-2012/31/atorvastatin-sole-funding-announced.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharmacytoday.co.nz/news/2012/may-2012/31/atorvastatin-sole-funding-announced.aspx'" tppabs="http://www.pharmacytoday.co.nz/news/2012/may-2012/31/atorvastatin-sole-funding-announced.aspx" class="external text external">the original</a> on 17 July 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">16 July</span> 2014</span>.</cite></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><a href="javascript:if(confirm('https://web.archive.org/web/20160505002923/https://www.highbeam.com/doc/1N1-142C233901743910.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160505002923/https://www.highbeam.com/doc/1N1-142C233901743910.html'" tppabs="https://web.archive.org/web/20160505002923/https://www.highbeam.com/doc/1N1-142C233901743910.html" class="external text external">"Ranbaxy recalls generic Lipitor doses"</a>, Associated Press in <i>Chicago Sun-Times</i>, 23 November 2012 <span>&nbsp;</span><span>–</span><span>&nbsp;</span><span>via</span><span>&nbsp;</span>HighBeam Research<span> </span><span style="font-size:0.95em; font-size:90%; color:#555">(subscription required)</span><span> </span></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite id="CITEREFJohnson2012" class="citation news cs1">Johnson LA (24 November 2012). <a href="javascript:if(confirm('https://www.bostonglobe.com/business/2012/11/24/ranbaxy-recalls-generic-lipitor-doses/iRsoUYfYzHStRzIe82LFCK/story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bostonglobe.com/business/2012/11/24/ranbaxy-recalls-generic-lipitor-doses/iRsoUYfYzHStRzIe82LFCK/story.html'" tppabs="https://www.bostonglobe.com/business/2012/11/24/ranbaxy-recalls-generic-lipitor-doses/iRsoUYfYzHStRzIe82LFCK/story.html" class="external text external">"Ranbaxy recalls generic Lipitor doses"</a>. <i>The Boston Globe</i>. Associated Press<span class="reference-accessdate">. Retrieved <span class="nowrap">29 December</span> 2017</span>.</cite></span></li><li id="cite_note-90"> <span id="mw-reference-text-cite_note-90" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/drugs/drugsafety/ucm329951.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/drugs/drugsafety/ucm329951.htm'" tppabs="https://www.fda.gov/drugs/drugsafety/ucm329951.htm" class="external text external">"FDA Statement on Ranbaxy Atorvastatin Recall"</a>. U.S. Food and Drug Administration (FDA). 30 December 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">19 April</span> 2014</span>.</cite></span></li><li id="cite_note-91"> <span id="mw-reference-text-cite_note-91" class="mw-reference-text"><cite id="CITEREFLoftus2014" class="citation news cs1">Loftus P (7 March 2014). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.wsj.com/articles/ranbaxy-recalls-more-than-64-000-bottles-of-generic-lipitor-in-u-s-1394226119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/ranbaxy-recalls-more-than-64-000-bottles-of-generic-lipitor-in-u-s-1394226119'" tppabs="https://www.wsj.com/articles/ranbaxy-recalls-more-than-64-000-bottles-of-generic-lipitor-in-u-s-1394226119" class="external text external">"Ranbaxy Recalls More Than 64,000 Bottles of Generic Lipitor in U.S."</a></span>. <i>The Wall Street Journal</i>.</cite></span></li><li id="cite_note-Washington_Post_2014-92"> <span id="mw-reference-text-cite_note-Washington_Post_2014-92" class="mw-reference-text"><cite id="CITEREFSiddiquiSikka2014" class="citation news cs1">Siddiqui Z, Sikka K (8 March 2014). <a href="javascript:if(confirm('https://www.washingtonpost.com/politics/indian-drugmaker-ranbaxy-recalls-more-than-64000-bottles-of-its-generic-version-of-lipitor/2014/03/08/e36a41b4-a716-11e3-a5fa-55f0c77bf39c_story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.washingtonpost.com/politics/indian-drugmaker-ranbaxy-recalls-more-than-64000-bottles-of-its-generic-version-of-lipitor/2014/03/08/e36a41b4-a716-11e3-a5fa-55f0c77bf39c_story.html'" tppabs="https://www.washingtonpost.com/politics/indian-drugmaker-ranbaxy-recalls-more-than-64000-bottles-of-its-generic-version-of-lipitor/2014/03/08/e36a41b4-a716-11e3-a5fa-55f0c77bf39c_story.html" class="external text external">"Indian drugmaker Ranbaxy recalls more than 64,000 bottles of its generic version of Lipitor"</a>. <i>The Washington Post</i><span class="reference-accessdate">. Retrieved <span class="nowrap">29 December</span> 2017</span>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<style data-mw-deduplicate="TemplateStyles:r886047268">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}</style><div class="refbegin reflist   columns references-column-width" style="-moz-column-width: 35em; -webkit-column-width: 35em; column-width: 35em;">
<ul><li><cite id="CITEREFMaggon2005" class="citation journal cs1">Maggon K (June 2005). "Best-selling human medicines 2002–2004". <i>Drug Discovery Today</i>. <b>10</b> (11): 739–42. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1359-6446%2805%2903468-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1359-6446%2805%2903468-9'" tppabs="https://doi.org/10.1016%2FS1359-6446%2805%2903468-9" class="external text external">10.1016/S1359-6446(05)03468-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15922927  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15922927'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15922927" class="external text external">15922927</a>.</cite></li>
<li><cite id="CITEREFSimons2003" class="citation web cs1">Simons J (20 January 2003). <a href="javascript:if(confirm('https://archive.fortune.com/magazines/fortune/fortune_archive/2003/01/20/335643/index.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.fortune.com/magazines/fortune/fortune_archive/2003/01/20/335643/index.htm'" tppabs="https://archive.fortune.com/magazines/fortune/fortune_archive/2003/01/20/335643/index.htm" class="external text external">"The $10 Billion Pill Hold the fries, please. Lipitor, the cholesterol-lowering medication, has become the bestselling pharmaceutical in history. Here's how Pfizer did it"</a>. <i>Fortune</i>.</cite></li>
<li><cite id="CITEREFWinslow2000" class="citation news cs1">Winslow R (24 January 2000). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.wsj.com/articles/SB948677773420632448  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/SB948677773420632448'" tppabs="https://www.wsj.com/articles/SB948677773420632448" class="external text external">"The Birth of a Blockbuster: Lipitor's Route out of the Lab"</a></span>. <i>The Wall Street Journal</i><span class="reference-accessdate">. Retrieved <span class="nowrap">26 October</span> 2011</span>.</cite></li></ul>
</div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/atorvastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/atorvastatin'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/atorvastatin" class="external text external">"Atorvastatin"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Lipid-modifying_agents_(C10)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Lipid-modifying_agents_(C10)" style="font-size:114%;margin:0 4em">Lipid-modifying agents (C10)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">GI tract</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Cholesterol absorption inhibitors, NPC1L1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ezetimibe.htm" tppabs="https://ptable.com/wiki/compounds/A/Ezetimibe" title="Ezetimibe">Ezetimibe</a></li>
<li>SCH-48461</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Bile acid sequestrants/resins (LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Colesevelam.htm" tppabs="https://ptable.com/wiki/compounds/A/Colesevelam" title="Colesevelam">Colesevelam</a></li>
<li>Colestilan</li>
<li><a href="Colestipol.htm" tppabs="https://ptable.com/wiki/compounds/A/Colestipol" title="Colestipol">Colestipol</a></li>
<li>Colestyramine</li>
<li>Colextran</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Liver</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Statins (HMG-CoA reductase, LDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atorvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Atorvastatin" title="Atorvastatin">Atorvastatin</a></li>
<li><a href="Cerivastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cerivastatin" title="Cerivastatin">Cerivastatin</a><sup>‡</sup></li>
<li><a href="Fluvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvastatin" title="Fluvastatin">Fluvastatin</a></li>
<li><a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li><a href="Mevastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li>Pitavastatin</li>
<li><a href="Pravastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pravastatin" title="Pravastatin">Pravastatin</a></li>
<li><a href="Rosuvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosuvastatin" title="Rosuvastatin">Rosuvastatin</a></li>
<li><a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">Simvastatin</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Niacin and derivatives (HDL and LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acipimox</li>
<li>Aluminium nicotinate</li>
<li><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin</a></li>
<li>Niceritrol</li>
<li><a href="Nicofuranose.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicofuranose" title="Nicofuranose">Nicofuranose</a></li>
<li><a href="Nicotinyl_alcohol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotinyl_alcohol" title="Nicotinyl alcohol">Nicotinyl alcohol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">MTTP inhibitors (VLDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dirlotapide</li>
<li>Lomitapide</li>
<li>Mitratapide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">ATP citrate lyase inhibitors (LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bempedoic acid</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Blood vessels</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Fibrates (PPAR)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aluminium clofibrate</li>
<li><a href="Bezafibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezafibrate" title="Bezafibrate">Bezafibrate</a></li>
<li><span class="new">Choline fenofibrate</span></li>
<li><a href="Ciprofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciprofibrate" title="Ciprofibrate">Ciprofibrate</a></li>
<li>Clinofibrate</li>
<li><a href="Clofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofibrate" title="Clofibrate">Clofibrate</a><sup>‡</sup></li>
<li>Clofibride</li>
<li>Etofibrate</li>
<li><a href="Fenofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenofibrate" title="Fenofibrate">Fenofibrate</a></li>
<li><a href="Gemfibrozil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemfibrozil" title="Gemfibrozil">Gemfibrozil</a></li>
<li>Pemafibrate</li>
<li>Ronifibrate</li>
<li>Simfibrate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CETP inhibitors (HDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Anacetrapib<sup>†</sup></li>
<li>Dalcetrapib<sup>§</sup></li>
<li>Evacetrapib<sup>§</sup></li>
<li><span class="new">Obicetrapib</span><sup>†</sup></li>
<li>Torcetrapib<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">PCSK9 inhibitors (LDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alirocumab</li>
<li>Bococizumab</li>
<li>Evolocumab</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bempedoic acid/ezetimibe</li>
<li>Ezetimibe/atorvastatin</li>
<li>Ezetimibe/rosuvastatin</li>
<li>Ezetimibe/simvastatin</li>
<li>Fenofibrate/pravastatin</li>
<li>Fenofibrate/simvastatin</li>
<li>Niacin/laropiprant</li>
<li>Niacin/lovastatin</li>
<li>Niacin/simvastatin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alipogene tiparvovec</li>
<li>Azacosterol</li>
<li>Azalanstat</li>
<li>Benfluorex<sup>‡</sup></li>
<li>Darapladib<sup>§</sup></li>
<li><a href="Dextrothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextrothyroxine" title="Dextrothyroxine">Dextrothyroxine</a><sup>‡</sup></li>
<li>Lapaquistat<sup>§</sup></li>
<li>Magnesium pyridoxal 5-phosphate glutamate</li>
<li><a href="Meglutol.htm" tppabs="https://ptable.com/wiki/compounds/A/Meglutol" title="Meglutol">Meglutol</a></li>
<li>Mipomersen</li>
<li>Omega-3-triglycerides</li>
<li>Policosanol</li>
<li><a href="Probucol.htm" tppabs="https://ptable.com/wiki/compounds/A/Probucol" title="Probucol">Probucol</a></li>
<li>Tiadenol</li>
<li>Triparanol<sup>‡</sup></li>
<li>Volanesorsen</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>









<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>